<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en" class="win-std-desktop-val"><head>
<META http-equiv="Content-Type" content="text/html">
<title>Source View: https://classic.clinicaltrials.gov/ct2/show/NCT04278768?term=NCT04278768&amp;draw=2&amp;rank=1</title><meta name="robots" content="noindex,nofollow"><meta name="SortSite-IgnoreRule-Page" content="AccHtmlLinkTextReused,AccAdvancedReadingLevel,Section508-m-3,BugHtmlColgroup,BugIeCssMinMaxWidthHeight,ErrSpellingError,SeoBingTitleLength,SeoPage150k,UseGov5.1,UseGov9.2.3,UseGov10.11,UseGov11.7,UseGov14.3,UseGov17.4,UseGunningFog,W3cTitleTooLong"><link rel="icon" href="https://www-powermapper-com.azureedge.net/favicon.ico"><link rel="stylesheet" href="../Report/report-min-20200618.css"><script type="text/javascript" src="../Report/report-min-20210409.js"></script><!--[if lte IE 8]>
            <script>
                document.createElement('header');
                document.createElement('aside');
            </script>
            <![endif]--></head><body class="source"><a class="accessible" href="#content">Skip to Content</a><header><h1>
                        HTML Document
                    </h1><table><tr><th>
                        URL:
                    </th><td><a rel="nofollow" target="_top" href="https://classic.clinicaltrials.gov/ct2/show/NCT04278768?term=NCT04278768&amp;draw=2&amp;rank=1">https://classic.clinicaltrials.gov/ct2/show/NCT04278768?term=NCT04278768&amp;draw=2&amp;rank=1</a></td></tr><tr><th>
                        HTTP Status:
                    </th><td>200 OK</td></tr><tr><th>
                        MIME Type:
                    </th><td>text/html </td></tr><tr><th>
                        Last Modified:
                    </th><td>Mon, 01 Jan 1601 00:00:00 GMT</td></tr><tr><th>
                        Download Time:
                    </th><td>1 seconds
                            </td></tr><tr><th>
                        Cookies:
                    </th><td> Psid=vihzm6CL8w0BLDF6myz3FQ7V  CTOpts=Qihzm6CL8w0BLDF6myUgzw  BIGipServerP_CLINT_80=3625062 </td></tr><tr><th>
                        Size:
                    </th><td>106 KB
                        </td></tr><tr><th>
                                Depth:
                            </th><td>4 clicks from home page
                            </td></tr><tr><th>
                                Charset:
                            </th><td>utf-8</td></tr><tr><th>
                                Forms:
                            </th><td>1 forms containing 3 controls
                            </td></tr><tr><th>
                        HTTP Headers:
                    </th><td><button class="chevron toggleChevron" data-toggleid="HttpHeaders"><img width="20" height="20" alt="View Headers" id="chevHttpHeaders" src="../Report/chevron-down.svg"></button>&nbsp;<span>9&nbsp;headers</span><div class="links" id="expand-HttpHeaders">Connection: close<br>Date: Wed, 27 Sep 2023 21:56:38 GMT<br>Server: Apache<br>Set-Cookie: BIGipServerP_CLINT_80=3625062018.16470.0000; path=/; Httponly<br>Strict-Transport-Security: max-age=31536000; includeSubDomains; preload<br>Transfer-Encoding: chunked<br>X-Frame-Options: SAMEORIGIN<br>X-UA-Compatible: IE=Edge<br>X-XSS-Protection: 1; mode=block<br></div></td></tr><tr><th>
                        Links In:
                    </th><td><button class="chevron toggleChevron" data-toggleid="LinksIn"><img width="20" height="20" alt="View Links" id="chevLinksIn" src="../Report/chevron-down.svg"></button>&nbsp;<span>1&nbsp;pages</span><div class="links" id="expand-LinksIn"><a class="viewsource" rel="nofollow" target="_top" href="https://content.montefioreeinstein.org/cancer/research/blood-institute/bci-research/translational-clinical-trials" data-pageid="6639" data-line="0" data-col="0">https://content.montefioreeinstein.org/cancer/research/blood-institute/bci-research/translational-clinical-trials</a><br></div></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr><tr class="middle"><th><img alt="OK" width="20" height="20" src="../Report/bench-better.svg">
                                Issues:
                            </th><td>
                                No issues found
                            </td></tr></table></header><main id="content" class="pre"><p><code>1</code><code>          </code></p><p><code>2</code><code>          </code></p><p><code>3</code><code>          </code></p><p><code>4</code><code>          </code></p><p><code>5</code><code>          </code></p><p><code>6</code><code>          </code></p><p><code>7</code><code>          </code></p><p><code>8</code><code>          </code></p><p><code>9</code><code>          </code></p><p><code>10</code><code>          </code></p><p><code>11</code><code>          </code></p><p><code>12</code><code>          </code></p><p><code>13</code><code>          </code></p><p><code>14</code><code>          </code></p><p><code>15</code><code>          </code></p><p><code>16</code><code>          </code></p><p><code>17</code><code>          </code></p><p><code>18</code><code>          </code></p><p><code>19</code><code>          </code></p><p><code>20</code><code>  </code></p><p><code>21</code><code>          </code></p><p><code>22</code><code>          </code></p><p><code>23</code><code>          </code></p><p><code>24</code><code>          </code></p><p><code>25</code><code>          </code></p><p><code>26</code><code>          </code></p><p><code>27</code><code>          </code></p><p><code>28</code><code>          </code></p><p><code>29</code><code>          </code></p><p><code>30</code><code>          </code></p><p><code>31</code><code>          </code></p><p><code>32</code><code>          </code></p><p><code>33</code><code>          </code></p><p><code>34</code><code>          </code></p><p><code>35</code><code>          </code></p><p><code>36</code><code>          </code></p><p><code>37</code><code>          </code></p><p><code>38</code><code>          </code></p><p><code>39</code><code>          </code></p><p><code>40</code><code>          </code></p><p><code>41</code><code>          </code></p><p><code>42</code><code>          </code></p><p><code>43</code><code>          </code></p><p><code>44</code><code>          </code></p><p><code>45</code><code>          </code></p><p><code>46</code><code>          </code></p><p><code>47</code><code>          </code></p><p><code>48</code><code>          </code></p><p><code>49</code><code>          </code></p><p><code>50</code><code>          </code></p><p><code>51</code><code>          </code></p><p><code>52</code><code>          </code></p><p><code>53</code><code>          </code></p><p><code>54</code><code>          </code></p><p><code>55</code><code>          </code></p><p><code>56</code><code>          </code></p><p><code>57</code><code>          </code></p><p><code>58</code><code>          </code></p><p><code>59</code><code>          </code></p><p><code>60</code><code>          </code></p><p><code>61</code><code>          </code></p><p><code>62</code><code>          </code></p><p><code>63</code><code>          </code></p><p><code>64</code><code>          </code></p><p><code>65</code><code>          </code></p><p><code>66</code><code>          </code></p><p><code>67</code><code>          </code></p><p><code>68</code><code>          </code></p><p><code>69</code><code>          </code></p><p><code>70</code><code>          </code></p><p><code>71</code><code>          </code></p><p><code>72</code><code>          </code></p><p><code>73</code><code>          </code></p><p><code>74</code><code>&lt;!DOCTYPE html&gt;</code></p><p><code>75</code><code>&lt;html xmlns="https://www.w3.org/1999/xhtml" lang='en'&gt;</code></p><p><code>76</code><code>&lt;head&gt;  </code></p><p><code>77</code><code>  &lt;meta http-equiv="X-UA-Compatible" content="IE=edge" /&gt;</code></p><p><code>78</code><code>  &lt;meta name="viewport" content="width=device-width, initial-scale=1"&gt;</code></p><p><code>79</code><code>  &lt;meta http-equiv="content-type" content="text/html; charset=UTF-8" /&gt;</code></p><p><code>80</code><code>    &lt;meta name="robots" content="noindex,nofollow"/&gt;</code></p><p><code>81</code><code>    &lt;meta name="referrer" content="origin-when-cross-origin"/&gt;</code></p><p><code>82</code><code>  &lt;title&gt;Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With AML or MDS - Full Text View - ClinicalTrials.gov&lt;/title&gt;</code></p><p><code>83</code><code>    &lt;link href="/ct2/show/NCT04278768" rel="canonical"/&gt;</code></p><p><code>84</code><code>    </code></p><p><code>85</code><code>  &lt;!-- Twitter Card data --&gt;</code></p><p><code>86</code><code>  &lt;meta name="twitter:card" content="summary"&gt;</code></p><p><code>87</code><code>  &lt;meta name="twitter:image" content="https://clinicaltrials.gov/ct2/html/images/ct.gov-nlm-nih-square-logo.png?v1"&gt;</code></p><p><code>88</code><code>          </code></p><p><code>89</code><code>  &lt;!-- Open Graph data --&gt;</code></p><p><code>90</code><code>  &lt;meta property="og:type" content="article" /&gt;</code></p><p><code>91</code><code>  &lt;meta property="og:title" content="Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With AML or MDS - Full Text View - ClinicalTrials.gov"&gt;</code></p><p><code>92</code><code>  &lt;meta property="og:image" content="https://clinicaltrials.gov/ct2/html/images/ct.gov-nlm-nih-square-logo.png?v1"&gt;</code></p><p><code>93</code><code>    &lt;meta property="og:description" content="Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With AML or MDS - Full Text View."&gt;</code></p><p><code>94</code><code>  &lt;meta property="og:url" content="https://clinicaltrials.gov/ct2/show/NCT04278768"&gt;</code></p><p><code>95</code><code>    </code></p><p><code>96</code><code>  &lt;link rel="shortcut icon" href="/ct2/html/images/favicon.ico" /&gt;</code></p><p><code>97</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-144x144.png' sizes='144x144'&gt;</code></p><p><code>98</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-114x114.png' sizes='114x114'&gt;</code></p><p><code>99</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-72x72.png'   sizes='72x72'&gt;</code></p><p><code>100</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-precomposed.png' &gt;</code></p><p><code>101</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon.png' &gt;</code></p><p><code>102</code><code>          </code></p><p><code>103</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/jquery/css/superfish.css?v=48" media="screen" /&gt;</code></p><p><code>104</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/jquery/css/superfish-vertical.css?v=48" media="screen" /&gt;</code></p><p><code>105</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/css/glossary.css?v=48" /&gt;</code></p><p><code>106</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/css/base.css?v=48" /&gt;</code></p><p><code>107</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/css/print.css?v=48" media="print" /&gt;</code></p><p><code>108</code><code>  &lt;link rel="stylesheet" href="/ct2/html/css/w3-ct.css?v=48" type="text/css" /&gt;</code></p><p><code>109</code><code>  &lt;!--[if lt IE 9]&gt;</code></p><p><code>110</code><code>	&lt;link rel="stylesheet" href="/ct2/html/css/w3-ct-oldIE.css?v=48" type="text/css" /&gt;</code></p><p><code>111</code><code>  &lt;![endif]--&gt;</code></p><p><code>112</code><code>   	</code></p><p><code>113</code><code>  &lt;link rel="preconnect" href="https://use.fontawesome.com"&gt;</code></p><p><code>114</code><code>  &lt;link rel="preconnect" href="https://www.ncbi.nlm.nih.gov"&gt;</code></p><p><code>115</code><code>  </code></p><p><code>116</code><code>  &lt;script src="https://use.fontawesome.com/20a31629ec.js"&gt;&lt;/script&gt;</code></p><p><code>117</code><code>&lt;!--[if lte IE 7]&gt;</code></p><p><code>118</code><code>       &lt;link href="/ct2/html/css/target-IE7-and-below.css" rel="stylesheet" type="text/css"&gt;</code></p><p><code>119</code><code>&lt;![endif]--&gt;</code></p><p><code>120</code><code>          </code></p><p><code>121</code><code>&lt;style type="text/css"&gt;</code></p><p><code>122</code><code>  h2 </code></p><p><code>123</code><code>  {</code></p><p><code>124</code><code>      background-color: #EAEAEA;</code></p><p><code>125</code><code>  }</code></p><p><code>126</code><code>&lt;/style&gt;</code></p><p><code>127</code><code>&lt;link href="/ct2/html/css/trial-record.css?v=48" rel="stylesheet" type="text/css" /&gt;</code></p><p><code>128</code><code>          </code></p><p><code>129</code><code>	&lt;script type="text/javascript" src="/ct2/html/jquery/js/jquery.min.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>130</code><code>&lt;script type="text/javascript" async src="/ct2/html/jquery/js/superclick.min.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>131</code><code>&lt;script type="text/javascript" async src="/ct2/html/js/ct.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>132</code><code>&lt;script type="text/javascript" async src="/ct2/html/js/ctmenu.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>133</code><code>&lt;script&gt;</code></p><p><code>134</code><code>var theURL = "/ct2/show/NCT04278768?term=NCT04278768&amp;draw=2&amp;rank=1"+window.location.hash;</code></p><p><code>135</code><code>history.replaceState(null,null,theURL);</code></p><p><code>136</code><code>&lt;/script&gt;</code></p><p><code>137</code><code>          </code></p><p><code>138</code><code>  &lt;meta name="ncbi_sid" content="4ec6157c5146f356_130e19SID"/&gt;</code></p><p><code>139</code><code>  &lt;meta name="ncbi_app" content="ctgov"/&gt;</code></p><p><code>140</code><code>  &lt;meta name="ncbi_db" content="ctgov"/&gt;</code></p><p><code>141</code><code>  &lt;meta name="ncbi_pdid" content="show_study"/&gt;</code></p><p><code>142</code><code>  &lt;meta name="ncbi_pcid" content="NCT04278768"/&gt;</code></p><p><code>143</code><code>  &lt;meta name="ncbi_ctreqid" content="R9A05mVp"/&gt;</code></p><p><code>144</code><code>  &lt;meta name="ncbi_ctsessid" content="S9A05FLV"/&gt;</code></p><p><code>145</code><code>  &lt;meta name="ncbi_ctipid" content="IjatRiK3"/&gt;</code></p><p><code>146</code><code>  &lt;meta name="ncbi_cthost" content="w11"/&gt;</code></p><p><code>147</code><code>  &lt;meta name="ncbi_ctterm" content="NCT04278768"/&gt;</code></p><p><code>148</code><code>  &lt;meta name="ncbi_ctrank" content="1"/&gt;</code></p><p><code>149</code><code>&lt;/head&gt;</code></p><p><code>150</code><code>          </code></p><p><code>151</code><code>          </code></p><p><code>152</code><code>&lt;body&gt; </code></p><p><code>153</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>154</code><code>    jQuery.getScript("https://www.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {</code></p><p><code>155</code><code>      galert(['#alert_banner', 'body &amp;gt; *:nth-child(1)'])});</code></p><p><code>156</code><code>&lt;/script&gt;</code></p><p><code>157</code><code>          </code></p><p><code>158</code><code>&lt;div id="alert_banner"&gt;&lt;/div&gt;</code></p><p><code>159</code><code>          </code></p><p><code>160</code><code>          </code></p><p><code>161</code><code>          </code></p><p><code>162</code><code>&lt;!-- eff6fb / aa0000; f9dede/black; ac2020/white --&gt;</code></p><p><code>163</code><code>&lt;!--</code></p><p><code>164</code><code>&lt;div style="display:flex; flex-direction:row; justify-content:center; background-color:#f9dede; margin-top:0px; padding: 10px 0 10px 0;"&gt;</code></p><p><code>165</code><code>    &lt;div style="text-align:center; color:black; font-size:18px; font-weight:700;"&gt;</code></p><p><code>166</code><code>        Maintenance test banner&lt;/br&gt;</code></p><p><code>167</code><code>        Line # 2</code></p><p><code>168</code><code>    &lt;/div&gt;</code></p><p><code>169</code><code>&lt;/div&gt;</code></p><p><code>170</code><code>--&gt;</code></p><p><code>171</code><code>          </code></p><p><code>172</code><code>&lt;div style="width:100%; height:8px; background-color:#ffbe2e;"&gt;&lt;/div&gt;</code></p><p><code>173</code><code>&lt;div id="longAlert" style="width:100%; background-color:#faf3d1; padding: 10px 0px; "&gt;</code></p><p><code>174</code><code>    &lt;div style="max-width: 1200px; margin: 0px auto; display:flex; align-items: center; font-size:14px; font-weight:700; padding:0px 8px;"&gt;</code></p><p><code>175</code><code>        &lt;div style="margin-right:1rem; display:flex; justify-content: center;"&gt;&lt;img src="/ct2/html/images/icon-disclaimer.png" width="24" height="24"/&gt;&lt;/div&gt;</code></p><p><code>176</code><code>        </code></p><p><code>177</code><code>                        &lt;div&gt;</code></p><p><code>178</code><code>            This is the classic website, which will be retired eventually. Please visit the modernized &lt;a href="https://www.clinicaltrials.gov" title="Follow link"&gt;ClinicalTrials.gov&lt;/a&gt; instead.</code></p><p><code>179</code><code>                    &lt;/div&gt;</code></p><p><code>180</code><code>    &lt;/div&gt;</code></p><p><code>181</code><code>&lt;/div&gt;</code></p><p><code>182</code><code>&lt;div style="width:100%; height:8px; background-color:#ffbe2e; margin-bottom:-8px;"&gt;&lt;/div&gt;</code></p><p><code>183</code><code>&lt;!--</code></p><p><code>184</code><code>&lt;div id="shortAlrt" style="display:block;margin-left:auto;margin-right:auto;border-bottom: 1px solid #aeb0b5;"&gt;</code></p><p><code>185</code><code>&amp;nbsp;</code></p><p><code>186</code><code>&lt;/div&gt;</code></p><p><code>187</code><code>--&gt;</code></p><p><code>188</code><code>          </code></p><p><code>189</code><code>          </code></p><p><code>190</code><code>          </code></p><p><code>191</code><code>          </code></p><p><code>192</code><code>&lt;!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--&gt;</code></p><p><code>193</code><code>&lt;script type='text/javascript'&gt;</code></p><p><code>194</code><code>/*</code></p><p><code>195</code><code>(function(){var g=function(e,h,f,g){</code></p><p><code>196</code><code>this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b&lt;e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null};</code></p><p><code>197</code><code>this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "};</code></p><p><code>198</code><code>this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&amp;&amp;(e=Math.random()&gt;=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0};</code></p><p><code>199</code><code>this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g+ "&amp;t=" + (new Date()).getTime();document.body&amp;&amp;document.body.appendChild(a)}};</code></p><p><code>200</code><code>this.start=function(){var a=this;window.addEventListener?window.addEventListener("load",function(){a.go()},!1):window.attachEvent&amp;&amp;window.attachEvent("onload",function(){a.go()})}};</code></p><p><code>201</code><code>try{(new g(100,"r","QSI_S_ZN_7WHWRcRMBs9xWYd","https://zn7whwrcrmbs9xwyd-nlmenterprise.siteintercept.qualtrics.com/WRSiteInterceptEngine/?Q_ZID=ZN_7WHWRcRMBs9xWYd")).start()}catch(i){}})();</code></p><p><code>202</code><code>*/</code></p><p><code>203</code><code>/*</code></p><p><code>204</code><code>$(window).on('error', function(e){</code></p><p><code>205</code><code>	// this will prevent error propagation from qualtrics</code></p><p><code>206</code><code>	// window.addEventListener('error', (e) =&gt; { e.preventDefault(); });</code></p><p><code>207</code><code>	// window.onerror = function(message, source, lineno, colno, error){ event.preventDefault(); });</code></p><p><code>208</code><code>	console.log('eondow.error', event.message)</code></p><p><code>209</code><code>	e.preventDefault();		// stop reporting (and maybe execution) of failed script</code></p><p><code>210</code><code>})</code></p><p><code>211</code><code>*/</code></p><p><code>212</code><code>(function () {</code></p><p><code>213</code><code>    var g = function (e, h, f, g) {</code></p><p><code>214</code><code>        this.get = function (a) {</code></p><p><code>215</code><code>            for (var a = a + "=", c = document.cookie.split(";"), b = 0, e = c.length; b &lt; e; b++) {</code></p><p><code>216</code><code>                for (var d = c[b]; " " == d.charAt(0); ) d = d.substring(1, d.length);</code></p><p><code>217</code><code>                if (0 == d.indexOf(a)) return d.substring(a.length, d.length);</code></p><p><code>218</code><code>            }</code></p><p><code>219</code><code>            return null;</code></p><p><code>220</code><code>        };</code></p><p><code>221</code><code>        this.set = function (a, c) {</code></p><p><code>222</code><code>            var b = "",</code></p><p><code>223</code><code>                b = new Date();</code></p><p><code>224</code><code>            b.setTime(b.getTime() + 6048e5);</code></p><p><code>225</code><code>            b = "; expires=" + b.toGMTString();</code></p><p><code>226</code><code>            document.cookie = a + "=" + c + b + "; path=/; ";</code></p><p><code>227</code><code>        };</code></p><p><code>228</code><code>        this.check = function () {</code></p><p><code>229</code><code>            var a = this.get(f);</code></p><p><code>230</code><code>            if (a) a = a.split(":");</code></p><p><code>231</code><code>            else if (100 != e) "v" == h &amp;&amp; (e = Math.random() &gt;= e / 100 ? 0 : 100), (a = [h, e, 0]), this.set(f, a.join(":"));</code></p><p><code>232</code><code>            else return !0;</code></p><p><code>233</code><code>            var c = a[1];</code></p><p><code>234</code><code>            if (100 == c) return !0;</code></p><p><code>235</code><code>            switch (a[0]) {</code></p><p><code>236</code><code>                case "v":</code></p><p><code>237</code><code>                    return !1;</code></p><p><code>238</code><code>                case "r":</code></p><p><code>239</code><code>                    return (c = a[2] % Math.floor(100 / c)), a[2]++, this.set(f, a.join(":")), !c;</code></p><p><code>240</code><code>            }</code></p><p><code>241</code><code>            return !0;</code></p><p><code>242</code><code>        };</code></p><p><code>243</code><code>        this.go = function () {</code></p><p><code>244</code><code>			try {</code></p><p><code>245</code><code>				if (this.check()) {</code></p><p><code>246</code><code>					var a = document.createElement("script");</code></p><p><code>247</code><code>					a.type = "text/javascript";</code></p><p><code>248</code><code>					a.src = g + "&amp;t=" + new Date().getTime();</code></p><p><code>249</code><code>					document.body &amp;&amp; document.body.appendChild(a);</code></p><p><code>250</code><code>				}</code></p><p><code>251</code><code>			}</code></p><p><code>252</code><code>			catch(ex) {}</code></p><p><code>253</code><code>        };</code></p><p><code>254</code><code>        this.start = function () {</code></p><p><code>255</code><code>            var a = this;</code></p><p><code>256</code><code>            window.addEventListener</code></p><p><code>257</code><code>                ? window.addEventListener(</code></p><p><code>258</code><code>                      "load",</code></p><p><code>259</code><code>                      function () {</code></p><p><code>260</code><code>                          a.go();</code></p><p><code>261</code><code>                      },</code></p><p><code>262</code><code>                      !1</code></p><p><code>263</code><code>                  )</code></p><p><code>264</code><code>                : window.attachEvent &amp;&amp;</code></p><p><code>265</code><code>                  window.attachEvent("onload", function () {</code></p><p><code>266</code><code>                      a.go();</code></p><p><code>267</code><code>                  });</code></p><p><code>268</code><code>        };</code></p><p><code>269</code><code>    };</code></p><p><code>270</code><code>    try {</code></p><p><code>271</code><code>        new g(100, "r", "QSI_S_ZN_7WHWRcRMBs9xWYd", "https://zn7whwrcrmbs9xwyd-nlmenterprise.siteintercept.qualtrics.com/WRSiteInterceptEngine/?Q_ZID=ZN_7WHWRcRMBs9xWYd").start();</code></p><p><code>272</code><code>    } catch (i) {}</code></p><p><code>273</code><code>})();</code></p><p><code>274</code><code>&lt;/script&gt;</code></p><p><code>275</code><code>&lt;div id='ZN_7WHWRcRMBs9xWYd'&gt;&lt;!--DO NOT REMOVE-CONTENTS PLACED HERE--&gt;&lt;/div&gt;</code></p><p><code>276</code><code>&lt;!--END WEBSITE FEEDBACK SNIPPET--&gt;</code></p><p><code>277</code><code>          </code></p><p><code>278</code><code>          </code></p><p><code>279</code><code>&lt;div id="glossary" class="glossary"</code></p><p><code>280</code><code>    aria-describedby="glossary-result" aria-hidden="true"&gt;</code></p><p><code>281</code><code>  &lt;button</code></p><p><code>282</code><code>      title="Close glossary"</code></p><p><code>283</code><code>      class="js-glossary-close button button--close js-glossary-toggle usa-button-unstyled"</code></p><p><code>284</code><code>    &gt;&lt;span class="usa-sr-only"&gt;Hide glossary&lt;/span&gt;</code></p><p><code>285</code><code>    &lt;i class="fa fa-times" aria-hidden="true"&gt;&lt;/i&gt;</code></p><p><code>286</code><code>  &lt;/button&gt;</code></p><p><code>287</code><code>  &lt;h4 class="glossary-heading"&gt;Glossary&lt;/h4&gt;</code></p><p><code>288</code><code>  &lt;p&gt;</code></p><p><code>289</code><code>  Study record managers: refer to the &lt;a href="https://classic.clinicaltrials.gov/ct2/manage-recs/resources#DataElement"&gt;&lt;span style="text-decoration:underline"&gt;Data Element Definitions&lt;/span&gt;&lt;/a&gt; if submitting registration or results information.</code></p><p><code>290</code><code>    &lt;/p&gt;</code></p><p><code>291</code><code>  &lt;p&gt;</code></p><p><code>292</code><code>  &lt;label for="glossary-search" class="label"&gt;Search for terms&lt;/label&gt;</code></p><p><code>293</code><code>  &lt;/p&gt;</code></p><p><code>294</code><code>  &lt;span class="clearable-input"&gt;</code></p><p><code>295</code><code>    &lt;input id="glossary-search" class="glossary__search js-glossary-search" type="search"&gt;</code></p><p><code>296</code><code>  &lt;/span&gt;</code></p><p><code>297</code><code>  &lt;div class="glossary__content" id="glossary-result"&gt;</code></p><p><code>298</code><code>    &lt;ul class="js-glossary-list"&gt;&lt;/ul&gt;</code></p><p><code>299</code><code>  &lt;/div&gt;</code></p><p><code>300</code><code>&lt;/div&gt;</code></p><p><code>301</code><code>          </code></p><p><code>302</code><code>          </code></p><p><code>303</code><code>          </code></p><p><code>304</code><code>          </code></p><p><code>305</code><code>&lt;script type="text/javascript" src="/ct2/html/js/working.js"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>306</code><code>&lt;div id="workingDim" class="ct-dim"&gt;</code></p><p><code>307</code><code>  &lt;div id="workingIndicator" class="ct-workingBox" style="text-align:center;vertical-align:middle;"&gt;</code></p><p><code>308</code><code>    &lt;img alt="Working&amp;#8230;" src="/ct2/html/images/working.gif" height="50" &gt;</code></p><p><code>309</code><code>  &lt;/div&gt;</code></p><p><code>310</code><code>&lt;/div&gt;</code></p><p><code>311</code><code>          </code></p><p><code>312</code><code>&lt;div id="wrapper"&gt; </code></p><p><code>313</code><code>&lt;div class="ct-inner_wrapper"&gt;   			&lt;a href="/ct2/home" style='float:left;border-bottom-width:0;min-width:200px;width:29%;'&gt;&lt;img src='/ct2/html/images/ct.gov-nlm-nih-logo.png' alt='ClinicalTrials.gov'/&gt;&lt;/a&gt;</code></p><p><code>314</code><code>          </code></p><p><code>315</code><code>				&lt;div id="hamburger" class="w3-hide-medium w3-hide-large" style="float:right;border-width:0;display:block;margin-left:1em;padding:4px;"</code></p><p><code>316</code><code>			title="Show menus"&gt;</code></p><p><code>317</code><code>			&lt;img src="/ct2/html/images/hamburgerMenuIcon.png" alt="ClinicalTrials.gov Menu" style="max-width:30px;cursor:pointer;" </code></p><p><code>318</code><code>			 onclick="$('#global-nav-popupMenu').toggle();"/&gt;</code></p><p><code>319</code><code>		&lt;/div&gt;</code></p><p><code>320</code><code>		&lt;div id="global-nav-popupMenu" class="w3-hide-medium w3-hide-large w3-modal w3-center" </code></p><p><code>321</code><code>			 style="display:none;" onclick="$('#global-nav-popupMenu').hide();"&gt; 			&lt;div id="global-nav-popupMenu-content" class="w3-modal-content"&gt;</code></p><p><code>322</code><code>				&lt;div class="w3-container"&gt;</code></p><p><code>323</code><code>				    &lt;span onclick="$('#global-nav-popupMenu').hide();"</code></p><p><code>324</code><code>				      class="w3-closebtn"&gt;&amp;times;&lt;/span&gt;</code></p><p><code>325</code><code>					&lt;ul class="sf-menu sf-vertical"&gt;</code></p><p><code>326</code><code>									&lt;li class="first"&gt;&lt;a href="/ct2/search/index"&gt;Find Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Find Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>327</code><code>			&lt;ul&gt;</code></p><p><code>328</code><code>                      &lt;li                  &gt;&lt;a                  href="/ct2/home"&gt;New Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>329</code><code>                      &lt;li                  &gt;&lt;a         href="/ct2/search/advanced"&gt;Advanced Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>330</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/search/browse?brwse=cond_cat"&gt;See Studies by Topic&lt;/a&gt;&lt;/li&gt;</code></p><p><code>331</code><code>                      &lt;li                  &gt;&lt;a             href="/ct2/search/map"&gt;See Studies on Map&lt;/a&gt;&lt;/li&gt;</code></p><p><code>332</code><code>                      &lt;li class="new-group"&gt;&lt;a           href="/ct2/help/how-find/index"&gt;How to Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>333</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/help/how-use-search-results"&gt;How to Use Search Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>334</code><code>                      &lt;li                  &gt;&lt;a        href="/ct2/help/how-find/find-study-results"&gt;How to Find Results of Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>335</code><code>                      &lt;li                  &gt;&lt;a          href="/ct2/help/how-read-study"&gt;How to Read a Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>336</code><code>			&lt;/ul&gt;</code></p><p><code>337</code><code>			&lt;/li&gt;</code></p><p><code>338</code><code>			&lt;li&gt;&lt;a href="/ct2/about-studies"&gt;About Studies&lt;img src="/ct2/html/images/pulldown.png" alt="About Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>339</code><code>			&lt;ul&gt;</code></p><p><code>340</code><code>                      &lt;li&gt;&lt;a href="/ct2/about-studies/learn"&gt;Learn About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>341</code><code>                      &lt;li&gt;&lt;a  href="/ct2/about-studies/other-sites"&gt;Other Sites About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>342</code><code>                      &lt;li&gt;&lt;a         href="/ct2/about-studies/glossary"&gt;Glossary of Common Site Terms&lt;/a&gt;&lt;/li&gt;</code></p><p><code>343</code><code>			&lt;/ul&gt;</code></p><p><code>344</code><code>			&lt;/li&gt;</code></p><p><code>345</code><code>			&lt;li&gt;&lt;a href="/ct2/manage-recs"&gt;Submit Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Submit Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>346</code><code>			&lt;ul&gt;</code></p><p><code>347</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/submit-study"&gt;Submit Studies to ClinicalTrials.gov PRS&lt;/a&gt;&lt;/li&gt;</code></p><p><code>348</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/background"&gt;Why Should I Register and Submit Results?&lt;/a&gt;&lt;/li&gt;</code></p><p><code>349</code><code>                      &lt;li&gt;&lt;a                                href="/ct2/manage-recs/fdaaa"&gt;FDAAA 801 and the Final Rule&lt;/a&gt;&lt;/li&gt;</code></p><p><code>350</code><code>                      &lt;li class="new-group"&gt;&lt;a    href="/ct2/manage-recs/how-apply"&gt;How to Apply for a PRS Account&lt;/a&gt;&lt;/li&gt;</code></p><p><code>351</code><code>                      &lt;li&gt;&lt;a                        href="/ct2/manage-recs/how-register"&gt;How to Register Your Study&lt;/a&gt;&lt;/li&gt;</code></p><p><code>352</code><code>                      &lt;li&gt;&lt;a                         href="/ct2/manage-recs/how-edit"&gt;How to Edit Your Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>353</code><code>                      &lt;li&gt;&lt;a                   href="/ct2/manage-recs/how-report"&gt;How to Submit Your Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>354</code><code>                      &lt;li class="new-group"&gt;&lt;a       href="/ct2/manage-recs/faq"&gt;Frequently Asked Questions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>355</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/manage-recs/resources"&gt;Support Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>356</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/manage-recs/present"&gt;Training Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>357</code><code>			&lt;/ul&gt;</code></p><p><code>358</code><code>			&lt;/li&gt;</code></p><p><code>359</code><code>			&lt;li&gt;&lt;a href="/ct2/resources"&gt;Resources&lt;img src="/ct2/html/images/pulldown.png" alt="Resources Menu"&gt;&lt;/a&gt;</code></p><p><code>360</code><code>			&lt;ul&gt;</code></p><p><code>361</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/resources/pubs"&gt;Selected Publications&lt;/a&gt;&lt;/li&gt;</code></p><p><code>362</code><code>                      &lt;li                  &gt;&lt;a       href="/ct2/resources/alert"&gt;Clinical Alerts and Advisories&lt;/a&gt;&lt;/li&gt;</code></p><p><code>363</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/resources/rss"&gt;RSS Feeds&lt;/a&gt;&lt;/li&gt;</code></p><p><code>364</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/resources/trends"&gt;Trends, Charts, and Maps&lt;/a&gt;&lt;/li&gt;</code></p><p><code>365</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/resources/download"&gt;Downloading Content for Analysis&lt;/a&gt;&lt;/li&gt;</code></p><p><code>366</code><code>			&lt;/ul&gt;</code></p><p><code>367</code><code>			&lt;/li&gt;</code></p><p><code>368</code><code>			&lt;li class="last"&gt;&lt;a href="/ct2/about-site"&gt;About Site&lt;img src="/ct2/html/images/pulldown.png" alt="About Site Menu"&gt;&lt;/a&gt;</code></p><p><code>369</code><code>			&lt;ul&gt;</code></p><p><code>370</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/about-site/new"&gt;What's New&lt;/a&gt;&lt;/li&gt;</code></p><p><code>371</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/background"&gt;ClinicalTrials.gov Background&lt;/a&gt;&lt;/li&gt;</code></p><p><code>372</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/results"&gt;About the Results Database&lt;/a&gt;&lt;/li&gt;</code></p><p><code>373</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/history"&gt;History, Policies, and Laws&lt;/a&gt;&lt;/li&gt;</code></p><p><code>374</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/modernization"&gt;ClinicalTrials.gov Modernization&lt;/a&gt;&lt;/li&gt;</code></p><p><code>375</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/about-site/for-media"&gt;Media/Press Resources&lt;/a&gt;&lt;/li&gt;</code></p><p><code>376</code><code>                      &lt;li class="new-group"&gt;&lt;a          href="/ct2/about-site/link-to"&gt;Linking to This Site&lt;/a&gt;&lt;/li&gt;</code></p><p><code>377</code><code>                      &lt;li                  &gt;&lt;a           href="/ct2/about-site/terms-conditions"&gt;Terms and Conditions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>378</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/about-site/disclaimer"&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>379</code><code>			&lt;/ul&gt;</code></p><p><code>380</code><code>			&lt;/li&gt;</code></p><p><code>381</code><code>			&lt;li&gt;&lt;a title="Login to the ClinicalTrials.gov Protocol Registration and Results System (PRS)"</code></p><p><code>382</code><code>				href="/ct2/manage-recs/register"&gt;&lt;span style="border-bottom:1px solid;padding-bottom:1px;padding-right:0;"&gt;PRS Login&lt;/span&gt;&lt;/a&gt;</code></p><p><code>383</code><code>			&lt;/li&gt;</code></p><p><code>384</code><code>								&lt;/ul&gt;</code></p><p><code>385</code><code>				&lt;/div&gt;</code></p><p><code>386</code><code>    		&lt;/div&gt;</code></p><p><code>387</code><code>  		&lt;/div&gt;		</code></p><p><code>388</code><code>		</code></p><p><code>389</code><code>&lt;div </code></p><p><code>390</code><code>style="float:right;margin-top:1.5%;" </code></p><p><code>391</code><code>class="w3-hide-small"&gt;</code></p><p><code>392</code><code>	&lt;ul class="sf-menu sf-vertical"&gt;</code></p><p><code>393</code><code>				&lt;li class="first"&gt;&lt;a href="/ct2/search/index"&gt;Find Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Find Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>394</code><code>			&lt;ul&gt;</code></p><p><code>395</code><code>                      &lt;li                  &gt;&lt;a                  href="/ct2/home"&gt;New Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>396</code><code>                      &lt;li                  &gt;&lt;a         href="/ct2/search/advanced"&gt;Advanced Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>397</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/search/browse?brwse=cond_cat"&gt;See Studies by Topic&lt;/a&gt;&lt;/li&gt;</code></p><p><code>398</code><code>                      &lt;li                  &gt;&lt;a             href="/ct2/search/map"&gt;See Studies on Map&lt;/a&gt;&lt;/li&gt;</code></p><p><code>399</code><code>                      &lt;li class="new-group"&gt;&lt;a           href="/ct2/help/how-find/index"&gt;How to Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>400</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/help/how-use-search-results"&gt;How to Use Search Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>401</code><code>                      &lt;li                  &gt;&lt;a        href="/ct2/help/how-find/find-study-results"&gt;How to Find Results of Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>402</code><code>                      &lt;li                  &gt;&lt;a          href="/ct2/help/how-read-study"&gt;How to Read a Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>403</code><code>			&lt;/ul&gt;</code></p><p><code>404</code><code>			&lt;/li&gt;</code></p><p><code>405</code><code>			&lt;li&gt;&lt;a href="/ct2/about-studies"&gt;About Studies&lt;img src="/ct2/html/images/pulldown.png" alt="About Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>406</code><code>			&lt;ul&gt;</code></p><p><code>407</code><code>                      &lt;li&gt;&lt;a href="/ct2/about-studies/learn"&gt;Learn About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>408</code><code>                      &lt;li&gt;&lt;a  href="/ct2/about-studies/other-sites"&gt;Other Sites About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>409</code><code>                      &lt;li&gt;&lt;a         href="/ct2/about-studies/glossary"&gt;Glossary of Common Site Terms&lt;/a&gt;&lt;/li&gt;</code></p><p><code>410</code><code>			&lt;/ul&gt;</code></p><p><code>411</code><code>			&lt;/li&gt;</code></p><p><code>412</code><code>			&lt;li&gt;&lt;a href="/ct2/manage-recs"&gt;Submit Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Submit Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>413</code><code>			&lt;ul&gt;</code></p><p><code>414</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/submit-study"&gt;Submit Studies to ClinicalTrials.gov PRS&lt;/a&gt;&lt;/li&gt;</code></p><p><code>415</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/background"&gt;Why Should I Register and Submit Results?&lt;/a&gt;&lt;/li&gt;</code></p><p><code>416</code><code>                      &lt;li&gt;&lt;a                                href="/ct2/manage-recs/fdaaa"&gt;FDAAA 801 and the Final Rule&lt;/a&gt;&lt;/li&gt;</code></p><p><code>417</code><code>                      &lt;li class="new-group"&gt;&lt;a    href="/ct2/manage-recs/how-apply"&gt;How to Apply for a PRS Account&lt;/a&gt;&lt;/li&gt;</code></p><p><code>418</code><code>                      &lt;li&gt;&lt;a                        href="/ct2/manage-recs/how-register"&gt;How to Register Your Study&lt;/a&gt;&lt;/li&gt;</code></p><p><code>419</code><code>                      &lt;li&gt;&lt;a                         href="/ct2/manage-recs/how-edit"&gt;How to Edit Your Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>420</code><code>                      &lt;li&gt;&lt;a                   href="/ct2/manage-recs/how-report"&gt;How to Submit Your Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>421</code><code>                      &lt;li class="new-group"&gt;&lt;a       href="/ct2/manage-recs/faq"&gt;Frequently Asked Questions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>422</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/manage-recs/resources"&gt;Support Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>423</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/manage-recs/present"&gt;Training Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>424</code><code>			&lt;/ul&gt;</code></p><p><code>425</code><code>			&lt;/li&gt;</code></p><p><code>426</code><code>			&lt;li&gt;&lt;a href="/ct2/resources"&gt;Resources&lt;img src="/ct2/html/images/pulldown.png" alt="Resources Menu"&gt;&lt;/a&gt;</code></p><p><code>427</code><code>			&lt;ul&gt;</code></p><p><code>428</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/resources/pubs"&gt;Selected Publications&lt;/a&gt;&lt;/li&gt;</code></p><p><code>429</code><code>                      &lt;li                  &gt;&lt;a       href="/ct2/resources/alert"&gt;Clinical Alerts and Advisories&lt;/a&gt;&lt;/li&gt;</code></p><p><code>430</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/resources/rss"&gt;RSS Feeds&lt;/a&gt;&lt;/li&gt;</code></p><p><code>431</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/resources/trends"&gt;Trends, Charts, and Maps&lt;/a&gt;&lt;/li&gt;</code></p><p><code>432</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/resources/download"&gt;Downloading Content for Analysis&lt;/a&gt;&lt;/li&gt;</code></p><p><code>433</code><code>			&lt;/ul&gt;</code></p><p><code>434</code><code>			&lt;/li&gt;</code></p><p><code>435</code><code>			&lt;li class="last"&gt;&lt;a href="/ct2/about-site"&gt;About Site&lt;img src="/ct2/html/images/pulldown.png" alt="About Site Menu"&gt;&lt;/a&gt;</code></p><p><code>436</code><code>			&lt;ul&gt;</code></p><p><code>437</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/about-site/new"&gt;What's New&lt;/a&gt;&lt;/li&gt;</code></p><p><code>438</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/background"&gt;ClinicalTrials.gov Background&lt;/a&gt;&lt;/li&gt;</code></p><p><code>439</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/results"&gt;About the Results Database&lt;/a&gt;&lt;/li&gt;</code></p><p><code>440</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/history"&gt;History, Policies, and Laws&lt;/a&gt;&lt;/li&gt;</code></p><p><code>441</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/modernization"&gt;ClinicalTrials.gov Modernization&lt;/a&gt;&lt;/li&gt;</code></p><p><code>442</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/about-site/for-media"&gt;Media/Press Resources&lt;/a&gt;&lt;/li&gt;</code></p><p><code>443</code><code>                      &lt;li class="new-group"&gt;&lt;a          href="/ct2/about-site/link-to"&gt;Linking to This Site&lt;/a&gt;&lt;/li&gt;</code></p><p><code>444</code><code>                      &lt;li                  &gt;&lt;a           href="/ct2/about-site/terms-conditions"&gt;Terms and Conditions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>445</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/about-site/disclaimer"&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>446</code><code>			&lt;/ul&gt;</code></p><p><code>447</code><code>			&lt;/li&gt;</code></p><p><code>448</code><code>			&lt;li&gt;&lt;a title="Login to the ClinicalTrials.gov Protocol Registration and Results System (PRS)"</code></p><p><code>449</code><code>				href="/ct2/manage-recs/register"&gt;&lt;span style="border-bottom:1px solid;padding-bottom:1px;padding-right:0;"&gt;PRS Login&lt;/span&gt;&lt;/a&gt;</code></p><p><code>450</code><code>			&lt;/li&gt;</code></p><p><code>451</code><code>				&lt;/ul&gt;</code></p><p><code>452</code><code>    &lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>453</code><code>&lt;/div&gt;</code></p><p><code>454</code><code>&lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>455</code><code>          </code></p><p><code>456</code><code>&lt;/div&gt; </code></p><p><code>457</code><code>&lt;div class="ct-outer_breadcrumb w3-container"&gt;</code></p><p><code>458</code><code>	&lt;div id="breadcrumb"&gt;</code></p><p><code>459</code><code>    &lt;ul class="ct-horz-list w3-left"&gt;</code></p><p><code>460</code><code>			&lt;li&gt;&lt;a href="/ct2/home"&gt;Home&lt;/a&gt;&lt;/li&gt;</code></p><p><code>461</code><code>												&lt;li&gt;&lt;a href="/ct2/results?term=NCT04278768&amp;amp;draw=2&amp;amp;rank=1"&gt;Search Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>462</code><code>										&lt;li&gt;Study Record Detail&lt;/li&gt;</code></p><p><code>463</code><code>    &lt;/ul&gt;</code></p><p><code>464</code><code>    &lt;div id="savedStudies" class="w3-right"&gt;</code></p><p><code>465</code><code>  	&lt;div id="cart" style="cursor:pointer;" onclick="location.href=('/ct2/results'+cartToURL()); showWorking();"&gt;</code></p><p><code>466</code><code>  	&lt;button class="ct-savedStudiesEnabled" id="open-cart-link" type="button" </code></p><p><code>467</code><code>  		onclick="location.href=('/ct2/results'+cartToURL()); showWorking();"</code></p><p><code>468</code><code>  		title="Show previously saved studies."&gt;Saved Studies&lt;/button&gt;</code></p><p><code>469</code><code>  	&lt;/div&gt;</code></p><p><code>470</code><code>&lt;/div&gt;</code></p><p><code>471</code><code>&lt;script type="text/javascript" src="/ct2/html/js/cart.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>472</code><code>          </code></p><p><code>473</code><code>		&lt;script type="text/javascript"&gt;</code></p><p><code>474</code><code>	$(document).ready(function(){</code></p><p><code>475</code><code>		$("input#saved").prop( 'checked', (inCart("NCT04278768")&gt;=0));</code></p><p><code>476</code><code>	});</code></p><p><code>477</code><code>&lt;/script&gt;</code></p><p><code>478</code><code>		&lt;div class="w3-right" style="margin-right: 1em;"&gt;</code></p><p><code>479</code><code>			&lt;label for="saved" title="Add or Remove this study in the Saved Studies list"&gt;&lt;input type="checkbox" id="saved" name="NCT04278768" onchange="updateCart('NCT04278768');" style="margin-left:1em;"&gt; Save this study &lt;/label&gt;</code></p><p><code>480</code><code>		&lt;/div&gt;</code></p><p><code>481</code><code>		&lt;div id="maxSavedStudies-popup" class="w3-modal" style="cursor:pointer;border:2px groove" onclick="$('#maxSavedStudies-popup').hide();"&gt;</code></p><p><code>482</code><code>	&lt;div id="maxSavedStudies-popup-content" class="w3-modal-content"&gt;</code></p><p><code>483</code><code>		&lt;div class="w3-display-container" style="border:1px solid #ccc;background-color:#eee;"&gt;</code></p><p><code>484</code><code>			&lt;form&gt;</code></p><p><code>485</code><code>			&lt;div class="w3-center" style="font-size:large;font-weight:bold;padding:3ex 1.5em;"&gt;</code></p><p><code>486</code><code>				&lt;img src="/ct2/html/images/warning.png" alt="Maximum Saved Studies Reached" style="max-width:1.0rem;cursor:pointer;"/&gt;</code></p><p><code>487</code><code>			    &lt;b&gt;Warning&lt;/b&gt;</code></p><p><code>488</code><code>				&lt;div style="margin-top:1ex;margin-bottom:0.5ex;"&gt;You have reached the maximum number of saved studies (100).&lt;/div&gt;</code></p><p><code>489</code><code>				&lt;div&gt;Please remove one or more studies before adding more.&lt;/div&gt;</code></p><p><code>490</code><code>			&lt;/div&gt;</code></p><p><code>491</code><code>		</code></p><p><code>492</code><code>			&lt;div class="w3-center" style="padding-bottom:1.5ex"&gt;</code></p><p><code>493</code><code>			  &lt;input class="ct-searchButton" type="button" style="opacity:1.0;font-weight:bold;font-size:inherit;padding:1.1ex 1em;" onclick="$('#maxSavedStudies-popup').hide();" value="Close" title="Close this dialog"/&gt;</code></p><p><code>494</code><code>			&lt;/div&gt;</code></p><p><code>495</code><code>			&lt;/form&gt;</code></p><p><code>496</code><code>		&lt;/div&gt;</code></p><p><code>497</code><code>	&lt;/div&gt;</code></p><p><code>498</code><code>&lt;/div&gt;</code></p><p><code>499</code><code>          </code></p><p><code>500</code><code>	&lt;/div&gt;</code></p><p><code>501</code><code>&lt;/div&gt;</code></p><p><code>502</code><code>          </code></p><p><code>503</code><code>&lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>504</code><code>          </code></p><p><code>505</code><code>&lt;div id="main-content" tabindex='-1'&gt;</code></p><p><code>506</code><code>	</code></p><p><code>507</code><code>	</code></p><p><code>508</code><code>		&lt;div class="tr-indent2"&gt;</code></p><p><code>509</code><code>        	&lt;div id="search-results" class="tr-search-results"&gt;</code></p><p><code>510</code><code>					&lt;div class="tr-results-summary"&gt;</code></p><p><code>511</code><code>				Trial record &lt;strong&gt;1 of 1&lt;/strong&gt; for:</code></p><p><code>512</code><code>		        &amp;nbsp;&amp;nbsp;  NCT04278768	        &lt;/div&gt;</code></p><p><code>513</code><code>	            &lt;div class="tr-results-nav"&gt;</code></p><p><code>514</code><code>         &lt;span class="grayed_fore_color"&gt;Previous Study&lt;/span&gt;         | &lt;a href="/ct2/results?term=NCT04278768&amp;amp;draw=2&amp;amp;rank=1" class="tr-return-link" &gt;Return to List&lt;/a&gt; |</code></p><p><code>515</code><code>         &lt;span class="grayed_fore_color"&gt;Next Study&lt;/span&gt; 		&lt;/div&gt;</code></p><p><code>516</code><code>	&lt;/div&gt;</code></p><p><code>517</code><code>	&lt;h1 class="tr-h1 ct-sans-serif"&gt;Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With AML or MDS&lt;/h1&gt;</code></p><p><code>518</code><code>          </code></p><p><code>519</code><code>  &lt;div class="w3-row"&gt;</code></p><p><code>520</code><code>    &lt;div class="w3-col m6"&gt;       &lt;div class="usa-alert usa-alert-warning" style="clear:both;margin:2ex 2em;"&gt;</code></p><p><code>521</code><code>        &lt;table&gt;</code></p><p><code>522</code><code>          &lt;tr&gt;</code></p><p><code>523</code><code>            &lt;td style="width:5%"&gt;</code></p><p><code>524</code><code>              &lt;img src="/ct2/html/images/warning.png" style="width:1.3em;" alt=""/&gt;</code></p><p><code>525</code><code>            &lt;/td&gt;</code></p><p><code>526</code><code>            &lt;td style="padding-right:2em;"&gt;</code></p><p><code>527</code><code>              The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.</code></p><p><code>528</code><code>                              &lt;a href="/ct2/about-studies/learn#Considerations"&gt;Know the risks and potential benefits&lt;/a&gt; of clinical studies and talk to your health care provider before participating.</code></p><p><code>529</code><code>                            Read our &lt;a href="/ct2/about-site/disclaimer"&gt;disclaimer&lt;/a&gt; for details.</code></p><p><code>530</code><code>            &lt;/td&gt;</code></p><p><code>531</code><code>          &lt;/tr&gt;</code></p><p><code>532</code><code>        &lt;/table&gt;</code></p><p><code>533</code><code>      &lt;/div&gt;      &lt;/div&gt; </code></p><p><code>534</code><code>&lt;!--</code></p><p><code>535</code><code>    &lt;div style="float:right;margin-right:4em"&gt;ClinicalTrials.gov Identifier: NCT04278768&lt;/div&gt;</code></p><p><code>536</code><code>--&gt;</code></p><p><code>537</code><code>    &lt;div class="w3-col m1"&gt;&amp;nbsp;&lt;/div&gt; </code></p><p><code>538</code><code>    &lt;div class="w3-col m5"&gt;       &lt;table style="width:95%"&gt;</code></p><p><code>539</code><code>        &lt;tr&gt;</code></p><p><code>540</code><code>          &lt;td&gt;ClinicalTrials.gov Identifier: NCT04278768&lt;/td&gt;</code></p><p><code>541</code><code>        &lt;/tr&gt;</code></p><p><code>542</code><code>        &lt;tr&gt;</code></p><p><code>543</code><code>          &lt;td&gt;</code></p><p><code>544</code><code>                          </code></p><p><code>545</code><code>                          </code></p><p><code>546</code><code>                                  &lt;div class="tr-status tr-recruiting-colors"&gt;</code></p><p><code>547</code><code>                                            &lt;span style="display:inline;" class="term" data-term="Recruitment Status" title="Show definition"&gt;Recruitment Status &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Recruitment Status" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; : </code></p><p><code>548</code><code>                                        Recruiting</code></p><p><code>549</code><code>                                                                  </code></p><p><code>550</code><code>                                              </code></p><p><code>551</code><code>            &lt;div style="font-size:inherit"&gt;</code></p><p><code>552</code><code>            &lt;span style="display:inline;" class="term" data-term="First Posted" title="Show definition"&gt;First Posted &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="First Posted" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; : February 20, 2020&lt;/div&gt;</code></p><p><code>553</code><code>                        &lt;div style="font-size:inherit"&gt;</code></p><p><code>554</code><code>            &lt;span style="display:inline;" class="term" data-term="Last Update Posted" title="Show definition"&gt;Last Update Posted &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Last Update Posted" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; : September 14, 2023&lt;/div&gt;</code></p><p><code>555</code><code>          </code></p><p><code>556</code><code>                          &lt;div style="margin-top:1ex; font-size:14px"&gt;</code></p><p><code>557</code><code>                &lt;span style="color:black;"&gt;See &lt;/span&gt;&lt;a href="#contacts"&gt;</code></p><p><code>558</code><code>                &lt;span class="ct-header2" style="font-size:inherit;"&gt; Contacts and Locations&lt;/span&gt;&lt;/a&gt;</code></p><p><code>559</code><code>              &lt;/div&gt;</code></p><p><code>560</code><code>            </code></p><p><code>561</code><code>                                    &lt;/div&gt;</code></p><p><code>562</code><code>          &lt;/td&gt;</code></p><p><code>563</code><code>        &lt;/tr&gt;</code></p><p><code>564</code><code>      &lt;/table&gt;</code></p><p><code>565</code><code>          </code></p><p><code>566</code><code>      &lt;!-- CTGDEV-1242 --&gt;</code></p><p><code>567</code><code>      &lt;div style="width:95%; margin-top:10px; padding: 0px 3px;"&gt;</code></p><p><code>568</code><code>        &lt;div style="padding: 15px 15px; background-color: #eff6fb; border: 5px #aacdec; border-style: solid none none none;"&gt;</code></p><p><code>569</code><code>        </code></p><p><code>570</code><code>          &lt;a href="https://clinicaltrials.gov/study/NCT04278768" target="_blank"&gt;View this study on the modernized ClinicalTrials.gov&lt;/a&gt;</code></p><p><code>571</code><code>                            &lt;/div&gt;</code></p><p><code>572</code><code>      &lt;/div&gt;</code></p><p><code>573</code><code>    &lt;/div&gt;    &lt;!-- div.w3-col.m5 --&gt;</code></p><p><code>574</code><code>  &lt;/div&gt;</code></p><p><code>575</code><code>          </code></p><p><code>576</code><code>  &lt;!-- CTGDEV-1242 --&gt;</code></p><p><code>577</code><code>  &lt;!--</code></p><p><code>578</code><code>  &lt;div style="float: right; width:41.66666%; margin-top:1rem; margin-left: 3rem; margin-bottom: 1rem;"&gt;</code></p><p><code>579</code><code>    &lt;div style="width:95%; background-color: #eff6fb; "&gt;</code></p><p><code>580</code><code>      &lt;div style="width:100%; height:.5rem; background-color: #aacdec;"&gt;&lt;/div&gt;</code></p><p><code>581</code><code>      &lt;div style="padding: 15px 15px;"&gt;</code></p><p><code>582</code><code>        &lt;a href="https://beta.clinicaltrials.gov/study/NCT04278768" target="_blank"&gt;View Record on Beta&lt;/a&gt;</code></p><p><code>583</code><code>      &lt;/div&gt;</code></p><p><code>584</code><code>    &lt;/div&gt;</code></p><p><code>585</code><code>  &lt;/div&gt;</code></p><p><code>586</code><code>  --&gt;</code></p><p><code>587</code><code>          </code></p><p><code>588</code><code>          </code></p><p><code>589</code><code>                &lt;div class="tr-info-title"&gt;Sponsor:&lt;/div&gt;</code></p><p><code>590</code><code>                &lt;div class="tr-info-text" id="sponsor"&gt; Curis, Inc. &lt;/div&gt;</code></p><p><code>591</code><code>          </code></p><p><code>592</code><code>                              &lt;div class="tr-info-title"&gt;Information provided by (Responsible Party):&lt;/div&gt;</code></p><p><code>593</code><code>                &lt;div class="tr-info-text" id="responsibleparty"&gt;Curis, Inc.&lt;/div&gt;</code></p><p><code>594</code><code>              	&lt;/div&gt;</code></p><p><code>595</code><code>&lt;br&gt;</code></p><p><code>596</code><code>          </code></p><p><code>597</code><code>    </code></p><p><code>598</code><code>&lt;div id="tabs"&gt;</code></p><p><code>599</code><code>    &lt;ul id="tab-links"&gt;</code></p><p><code>600</code><code>		&lt;li id="full-text"  class="current"&gt;Study Details     &lt;/li&gt;</code></p><p><code>601</code><code>		&lt;li id="tabular"   &gt;&lt;a href="/ct2/show/record/NCT04278768?term=NCT04278768&amp;amp;draw=2&amp;amp;rank=1" &gt;Tabular View&lt;/a&gt;&lt;/li&gt;</code></p><p><code>602</code><code>  					&lt;li id="results"   &gt;&lt;a href="/ct2/show/results/NCT04278768?term=NCT04278768&amp;amp;draw=2&amp;amp;rank=1"&gt;No Results Posted&lt;/a&gt;&lt;/li&gt;</code></p><p><code>603</code><code>						&lt;li id="disclaimer"&gt;&lt;a title="Disclaimer - opens new window"  href="/ct2/about-site/disclaimer" onclick="openNewWindow('/ct2/about-site/disclaimer'); return false"</code></p><p><code>604</code><code>&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>605</code><code>		&lt;li id="howtoread"&gt;&lt;a title="How to Read a Study Record - opens new window"  href="/ct2/help/how-read-study" onclick="openNewWindow('/ct2/help/how-read-study'); return false"</code></p><p><code>606</code><code>&gt;How to Read a Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>607</code><code>    &lt;/ul&gt;</code></p><p><code>608</code><code>&lt;/div&gt;  &lt;!--</code></p><p><code>609</code><code>&lt;div style="background-color:#f6f6f6;margin-top:5.0ex;padding-bottom:1.5ex;"&gt; &lt;/div&gt;</code></p><p><code>610</code><code>--&gt;</code></p><p><code>611</code><code>		</code></p><p><code>612</code><code>	&lt;div id="tab-body"&gt;</code></p><p><code>613</code><code>		&lt;div class="tr-indent2" style="background-color:white;"&gt;</code></p><p><code>614</code><code>						  </code></p><p><code>615</code><code>&lt;!-- purpose_section --&gt;</code></p><p><code>616</code><code>&lt;div class="tr-indent1" style="margin-top:1ex"&gt;</code></p><p><code>617</code><code>          </code></p><p><code>618</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>619</code><code>	&lt;div class="ct-header2"&gt;&lt;a id="studydesc"&gt;&lt;/a&gt;Study Description&lt;/div&gt;</code></p><p><code>620</code><code>	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>621</code><code>	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>622</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>623</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>624</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>625</code><code>&lt;/button&gt;</code></p><p><code>626</code><code>          </code></p><p><code>627</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>628</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>629</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>630</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>631</code><code>          </code></p><p><code>632</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>633</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>634</code><code>    </code></p><p><code>635</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>636</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>637</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>638</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>639</code><code>  &lt;/div&gt;</code></p><p><code>640</code><code>&lt;/div&gt;</code></p><p><code>641</code><code>&lt;/div&gt;</code></p><p><code>642</code><code>          </code></p><p><code>643</code><code>&lt;div class="tr-indent2" style="margin-top:2ex"&gt;</code></p><p><code>644</code><code>          </code></p><p><code>645</code><code>  &lt;div class="ct-body3"&gt;Brief Summary:&lt;/div&gt;</code></p><p><code>646</code><code>  &lt;div class="ct-body3 tr-indent2"&gt;&lt;p style="margin-top:1ex; margin-bottom:1ex;"&gt;This is a multicenter, open-label, Phase 1/2a dose escalation and expansion study of orally administered emavusertib (CA-4948) monotherapy in adult patients with Acute Myelogenous Leukemia (AML) or high risk Myelodysplastic Syndrome (MDS).&lt;/p&gt;</code></p><p><code>647</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Patients enrolling in the Phase 1 portion of the study must meet one of the following criteria prior to consenting to the study:&lt;/p&gt;</code></p><p><code>648</code><code>  &lt;ul style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>649</code><code>    &lt;li style="margin-top:0.7ex;"&gt;R/R AML with FLT3 mutations who have been previously treated with a FLT3 inhibitor&lt;/li&gt;</code></p><p><code>650</code><code>    &lt;li style="margin-top:0.7ex;"&gt;R/R AML with spliceosome mutations of SF3B1 or U2AF1&lt;/li&gt;</code></p><p><code>651</code><code>    &lt;li style="margin-top:0.7ex;"&gt;R/R hrMDS with spliceosome mutations of SF3B1 or U2AF1&lt;/li&gt;</code></p><p><code>652</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Number of pretreatments: 1 or 2&lt;/li&gt;</code></p><p><code>653</code><code>  &lt;/ul&gt;</code></p><p><code>654</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;The Phase 2a Dose Expansion will be in 3 Cohorts of patients:&lt;/p&gt;</code></p><p><code>655</code><code>  &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>656</code><code>    &lt;li style="margin-top:0.7ex;"&gt;R/R AML with FLT3 mutations who have been previously treated with a FLT3 inhibitor;&lt;/li&gt;</code></p><p><code>657</code><code>    &lt;li style="margin-top:0.7ex;"&gt;R/R AML with spliceosome mutations of SF3B1 or U2AF1; and&lt;/li&gt;</code></p><p><code>658</code><code>    &lt;li style="margin-top:0.7ex;"&gt;R/R hrMDS (IPSS-R score &amp;gt; 3.5) with spliceosome mutations of SF3B1 or U2AF1.&lt;/li&gt;</code></p><p><code>659</code><code>  &lt;/ol&gt;</code></p><p><code>660</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;All patients above have had &amp;#8804; 2 lines of prior systemic anticancer treatment. In previous versions of this protocol there was a Phase 1b portion of the study, in which patients with AML or hrMDS received CA-4948 in combination with venetoclax. This part of the study is no longer open for enrollment.&lt;/p&gt;&lt;/div&gt;&lt;br/&gt;</code></p><p><code>661</code><code>          </code></p><p><code>662</code><code>    &lt;!-- condition, intervention, phase summary table --&gt;</code></p><p><code>663</code><code>  &lt;table class="ct-data_table tr-data_table" border="1" style="margin:auto;width:80%;"&gt;</code></p><p><code>664</code><code>    &lt;tr style="text-align:left;"&gt;</code></p><p><code>665</code><code>            &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>666</code><code>&lt;span style="display:inline;" class="term" data-term="Condition/disease" title="Show definition"&gt;Condition or disease &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Condition/disease" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;       &lt;/th&gt;</code></p><p><code>667</code><code>                  &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>668</code><code>&lt;span style="display:inline;" class="term" data-term="Intervention/treatment" title="Show definition"&gt;Intervention/treatment &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Intervention/treatment" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;       &lt;/th&gt;</code></p><p><code>669</code><code>                  &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>670</code><code>&lt;span style="display:inline;" class="term" data-term="Phase" title="Show definition"&gt;Phase &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Phase" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;       &lt;/th&gt;</code></p><p><code>671</code><code>          &lt;/tr&gt;</code></p><p><code>672</code><code>    &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>673</code><code>            &lt;td class="ct-body3"&gt;</code></p><p><code>674</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Acute Myelogenous Leukemia&lt;/span&gt;</code></p><p><code>675</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Myelodysplastic Syndrome&lt;/span&gt;</code></p><p><code>676</code><code>              &lt;/td&gt;</code></p><p><code>677</code><code>                  &lt;td class="ct-body3"&gt;</code></p><p><code>678</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Drug: Emavusertib&lt;/span&gt;</code></p><p><code>679</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Drug: Venetoclax&lt;/span&gt;</code></p><p><code>680</code><code>              &lt;/td&gt;</code></p><p><code>681</code><code>                  &lt;td class="ct-body3" style="white-space:nowrap;"&gt;</code></p><p><code>682</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Phase 1&lt;/span&gt;</code></p><p><code>683</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Phase 2&lt;/span&gt;</code></p><p><code>684</code><code>              &lt;/td&gt;</code></p><p><code>685</code><code>          &lt;/tr&gt;</code></p><p><code>686</code><code>  &lt;/table&gt;</code></p><p><code>687</code><code>  &lt;br/&gt;</code></p><p><code>688</code><code>  </code></p><p><code>689</code><code>  </code></p><p><code>690</code><code>      &lt;a id="desc"&gt;&lt;/a&gt;</code></p><p><code>691</code><code>          </code></p><p><code>692</code><code>          &lt;script type="text/javascript" async src="/ct2/html/js/ExpandCollapseScript.js"&gt;&lt;/script&gt;</code></p><p><code>693</code><code>      </code></p><p><code>694</code><code>      &lt;div id="EXPAND_CONTROL-DetailedDesc" class="EXPAND tr-showAndHide" style="margin-bottom:2ex;"</code></p><p><code>695</code><code>        onclick="toggleSectionAndControls('-DetailedDesc');document.getElementById('desc').scrollIntoView({behavior: 'smooth', block: 'start'});" </code></p><p><code>696</code><code>        title="Show detailed description"&gt;</code></p><p><code>697</code><code>        &lt;img src="/ct2/html/images/expand.png" alt="Show"&gt; </code></p><p><code>698</code><code>        &lt;span style="padding-bottom:3px"&gt; Show detailed description&lt;/span&gt;</code></p><p><code>699</code><code>      &lt;/div&gt;</code></p><p><code>700</code><code>      &lt;div  id="COLLAPSE_CONTROL-DetailedDesc" class="COLLAPSE tr-showAndHide" style="margin-bottom:2ex;display:none"</code></p><p><code>701</code><code>        onclick="toggleSectionAndControls('-DetailedDesc');" </code></p><p><code>702</code><code>        title="Hide detailed description"&gt;</code></p><p><code>703</code><code>        &lt;img src="/ct2/html/images/collapse.png"  alt="Hide"&gt;</code></p><p><code>704</code><code>        &lt;span style="padding-bottom:3px"&gt; Hide detailed description&lt;/span&gt;</code></p><p><code>705</code><code>      &lt;/div&gt;</code></p><p><code>706</code><code>    </code></p><p><code>707</code><code>    &lt;!-- detailed description --&gt;</code></p><p><code>708</code><code>    &lt;div id="COLLAPSE-DetailedDesc" class="COLLAPSE"  style="margin-bottom:2ex;display:none;"&gt;</code></p><p><code>709</code><code>      &lt;div class="ct-body3"&gt;&lt;a id="detaileddesc"&gt;&lt;/a&gt;Detailed Description:&lt;/div&gt;</code></p><p><code>710</code><code>      &lt;div class="ct-body3 tr-indent2"&gt;&lt;p style="margin-top:1ex; margin-bottom:1ex;"&gt;The primary objective of the Phase 1 portion of the study is to determine the maximum tolerated dose (MTD) and Recommended Phase 2 Dose (RP2D) for emavusertib in monotherapy in patients with AML, intermediate high risk, high risk MDS based on the safety and tolerability, dose-limiting toxicities (DLTs), and Pharmacokinetic (PK)/Pharmacodynamic (PD) findings.&lt;/p&gt;</code></p><p><code>711</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;The primary objective of the Phase 1b portion of the study is to determine MTD and RP2D for emavusertib in combination with azacitidine (AZA) in treatment na&amp;#239;ve patients with hrMDS or in combination with venetoclax (VEN) in relapsed/ refractory (R/R) patients with AML or high risk myelodysplastic syndrome (hrMDS) after first line treatment based on the safety and tolerability, DLTs and PK and pharmacodynamic findings. Note, this portion of the study is no longer enrolling patients.&lt;/p&gt;</code></p><p><code>712</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;The primary objective of the Phase 2a portion of the study (emavusertib monotherapy expansion) is to assess anti-cancer activity of CA-4948 at the RP2D in patients with R/R AML with FMS-like tyrosine kinase-3 (FLT-3) mutations, or patients with R/R hrMDS or R/R AML with spliceosome mutations of SF3B1 or U2AF1.&lt;/p&gt;</code></p><p><code>713</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Emavusertib is formulated as tablets for twice daily oral administration. Each treatment cycle will be 28 days in length and repeated in the absence of toxicity. Patients who tolerate emavusertib may continue to receive emavusertib until progression of disease, intolerable toxicity, lack of clinical benefit, withdrawal from the trial, or study termination.&lt;/p&gt;</code></p><p><code>714</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;The emavusertib starting dose level will be 200 mg twice daily (BID) which was determined to be safe, capable of achieving relevant levels of drug exposure as well as demonstrating signs of biologic activity and clinical efficacy in an ongoing study (Study CA-4948-101). For phase 1, emavusertib is taken daily for 28 days of a 28 day cycle. For Phase 1b, emavusertib is taken daily for 21 days of a 28 day cycle in combination with venetoclax.&lt;/p&gt;</code></p><p><code>715</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Venetoclax will be administered at 100 mg orally (Day 1) per the product label at the same time each day with a ramp up over 3 days to 400 mg for 21 days of the 28-day Cycle. Second and subsequent cycles start with the target dose level.&lt;/p&gt;</code></p><p><code>716</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;In each of the Phase 1/1b cohorts, three patients with AML or MDS were enrolled at the designated dose. If none of the first 3 patients experience a DLT during the first cycle, patients may be enrolled into the next higher dose level. If 1 patient out of the first 3 experiences a DLT, the dose level may be expanded with an additional 3 patients. If 2 or 3 patients out of the first six experienced a DLT, this will be considered a DLT rate above the MTD (&amp;gt; 33%), and additional enrollment will proceed at a lower dose level. Any adverse reaction that lead to dose reduction or discontinuation is considered a DLT unless the adverse reaction is clearly and solely related to disease.&lt;/p&gt;</code></p><p><code>717</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;The RP2D will be determined by the Clinical Safety Committee (CSC) in consultation with the Sponsor, considering all aspects of safety, tolerability, biologic activity, pharmacokinetics and preliminary efficacy in the trial population. The intent of the RP2D is to provide a dose and schedule that will maximize the opportunity for clinical benefit, while minimizing the risk of toxicity. The RP2D may be below the MTD. The CSC may request enrollment of additional patients at any previously-explored dose level in order to make an appropriate RP2D or MTD determination.&lt;/p&gt;</code></p><p><code>718</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;The expansion phase will begin once the RP2D from Phase 1 Dose Escalation phase has been identified. There will be 3 Cohorts and patients will be assigned to each Cohort based on baseline disease:&lt;/p&gt;</code></p><p><code>719</code><code>  &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>720</code><code>    &lt;li style="margin-top:0.7ex;"&gt;R/R AML with FLT3 mutations who have been previously treated with a FLT3 inhibitor;&lt;/li&gt;</code></p><p><code>721</code><code>    &lt;li style="margin-top:0.7ex;"&gt;R/R AML with spliceosome mutations of SF3B1 or U2AF1; and&lt;/li&gt;</code></p><p><code>722</code><code>    &lt;li style="margin-top:0.7ex;"&gt;R/R hrMDS (IPSS-R score &amp;gt; 3.5) with spliceosome mutations of SF3B1 or U2AF1&lt;/li&gt;</code></p><p><code>723</code><code>  &lt;/ol&gt;</code></p><p><code>724</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;All patients have had &amp;#8804; 2 lines of prior systemic anticancer treatment.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>725</code><code>    &lt;/div&gt;</code></p><p><code>726</code><code>&lt;/div&gt; </code></p><p><code>727</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>728</code><code>  &lt;div class="ct-header2"&gt;&lt;a id="studydesign"&gt;&lt;/a&gt;Study Design&lt;/div&gt;</code></p><p><code>729</code><code>  &lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>730</code><code>  &lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>731</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>732</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>733</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>734</code><code>&lt;/button&gt;</code></p><p><code>735</code><code>          </code></p><p><code>736</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>737</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>738</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>739</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>740</code><code>          </code></p><p><code>741</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>742</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>743</code><code>    </code></p><p><code>744</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>745</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>746</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>747</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>748</code><code>  &lt;/div&gt;</code></p><p><code>749</code><code>&lt;/div&gt;</code></p><p><code>750</code><code>&lt;/div&gt;</code></p><p><code>751</code><code>          </code></p><p><code>752</code><code>  &lt;p&gt;</code></p><p><code>753</code><code>  &lt;table class="ct-layout_table tr-tableStyle tr-studyInfo" style="margin-bottom:2ex;"&gt;</code></p><p><code>754</code><code>   &lt;caption&gt;Layout table for study information&lt;/caption&gt;</code></p><p><code>755</code><code>   &lt;thead&gt;</code></p><p><code>756</code><code>    &lt;tr&gt;</code></p><p><code>757</code><code>      &lt;th id="studyInfoColTitle"&gt;&lt;/th&gt;</code></p><p><code>758</code><code>      &lt;th id="studyInfoColData"&gt;&lt;/th&gt;</code></p><p><code>759</code><code>    &lt;/tr&gt;</code></p><p><code>760</code><code>    &lt;/thead&gt;</code></p><p><code>761</code><code>    &lt;tbody&gt;</code></p><p><code>762</code><code>        &lt;tr&gt;</code></p><p><code>763</code><code>      &lt;td headers="studyInfoColTitle"&gt;</code></p><p><code>764</code><code>&lt;span style="display:inline;" class="term" data-term="Study Type" title="Show definition"&gt;Study Type &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Study Type" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>765</code><code>      &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;</code></p><p><code>766</code><code>        Interventional</code></p><p><code>767</code><code>                &amp;nbsp;(Clinical Trial)</code></p><p><code>768</code><code>                </code></p><p><code>769</code><code>        </code></p><p><code>770</code><code>      &lt;/td&gt;</code></p><p><code>771</code><code>    &lt;/tr&gt;</code></p><p><code>772</code><code>                    &lt;tr&gt;</code></p><p><code>773</code><code>      &lt;td headers="studyInfoColTitle"&gt;Estimated</code></p><p><code>774</code><code>&lt;span style="display:inline;" class="term" data-term="Enrollment" title="Show definition"&gt;Enrollment &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Enrollment" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>775</code><code>      &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;366 participants&lt;/td&gt;</code></p><p><code>776</code><code>    &lt;/tr&gt;</code></p><p><code>777</code><code>                &lt;tr&gt;</code></p><p><code>778</code><code>            &lt;td headers="studyInfoColTitle"&gt;Allocation:&lt;/td&gt;</code></p><p><code>779</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;Non-Randomized&lt;/td&gt;</code></p><p><code>780</code><code>    &lt;/tr&gt;</code></p><p><code>781</code><code>        &lt;tr&gt;</code></p><p><code>782</code><code>            &lt;td headers="studyInfoColTitle"&gt;Intervention Model:&lt;/td&gt;</code></p><p><code>783</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;Sequential Assignment&lt;/td&gt;</code></p><p><code>784</code><code>    &lt;/tr&gt;</code></p><p><code>785</code><code>        &lt;tr&gt;</code></p><p><code>786</code><code>            &lt;td headers="studyInfoColTitle"&gt;Intervention Model Description:&lt;/td&gt;</code></p><p><code>787</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt; Phase 1 and 1b follow a 3 + 3 design where 3 patients will be enrolled at the starting dose level. If none of the first 3 patients experience a Dose Limiting Toxicity (DLT) during the 1st cycle, patients may be enrolled into the next higher dose level. If 1 patient out of the first 3 experiences a DLT, the dose level may be expanded with an additional 3 patients. If 2 or 3 patients out of the first sixz experience a DLT, this will be considered a DLT rate above the max tolerated dose (&amp;gt; 33%), and additional enrollment will proceed at a lower dose level. The Phase 2a Dose Expansion will be enrolled after the RP2D is determined from Phase 1. It will be in 3 Cohorts of patients: (1) R/R AML with FTLT-3 mutation who have been previously treated with a FLT3 inhibitor; (2) R/R AML with spliceosome mutations of SF3B1 or U2AF1; and (3) R/R hrMDS (IPSS-R &amp;gt;3.5) with spliceosome mutations of SF3B1 or U2AF1; AND all patients have &amp;#8804; 2 lines of prior systemic anti-cancer therapy.&lt;/td&gt;</code></p><p><code>788</code><code>    &lt;/tr&gt;</code></p><p><code>789</code><code>        &lt;tr&gt;</code></p><p><code>790</code><code>            &lt;td headers="studyInfoColTitle"&gt;Masking:&lt;/td&gt;</code></p><p><code>791</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt; None (Open Label)&lt;/td&gt;</code></p><p><code>792</code><code>    &lt;/tr&gt;</code></p><p><code>793</code><code>        &lt;tr&gt;</code></p><p><code>794</code><code>            &lt;td headers="studyInfoColTitle"&gt;Primary Purpose:&lt;/td&gt;</code></p><p><code>795</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt; Treatment&lt;/td&gt;</code></p><p><code>796</code><code>    &lt;/tr&gt;</code></p><p><code>797</code><code>                    &lt;tr&gt;</code></p><p><code>798</code><code>&lt;!--</code></p><p><code>799</code><code>      &lt;td headers="studyInfoColTitle" style="padding-top:2ex;"&gt;Official Title:&lt;/td&gt;</code></p><p><code>800</code><code>--&gt;</code></p><p><code>801</code><code>      &lt;td headers="studyInfoColTitle"&gt;Official Title:&lt;/td&gt;</code></p><p><code>802</code><code>      &lt;td headers="studyInfoColData" style="padding-left:1em;"&gt;A Phase 1/2A, Open Label Dose Escalation and Expansion Study of Orally Administered CA-4948 as a Monotherapy in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome&lt;/td&gt;</code></p><p><code>803</code><code>    &lt;/tr&gt;</code></p><p><code>804</code><code>    </code></p><p><code>805</code><code>            &lt;tr&gt;</code></p><p><code>806</code><code>        &lt;td headers="studyInfoColTitle"&gt;  Actual &lt;span style="display:inline;" class="term" data-term="Study Start Date" title="Show definition"&gt;Study Start Date &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Study Start Date" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>807</code><code>        &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;July 6, 2020&lt;/td&gt;</code></p><p><code>808</code><code>      &lt;/tr&gt;</code></p><p><code>809</code><code>                  &lt;tr&gt;</code></p><p><code>810</code><code>        &lt;td headers="studyInfoColTitle"&gt;  Estimated &lt;span style="display:inline;" class="term" data-term="Primary Completion Date" title="Show definition"&gt;Primary Completion Date &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Primary Completion Date" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>811</code><code>        &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;April 1, 2026&lt;/td&gt;</code></p><p><code>812</code><code>      &lt;/tr&gt;</code></p><p><code>813</code><code>                  &lt;tr&gt;</code></p><p><code>814</code><code>        &lt;td headers="studyInfoColTitle"&gt;  Estimated &lt;span style="display:inline;" class="term" data-term="Study Completion Date" title="Show definition"&gt;Study Completion Date &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Study Completion Date" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>815</code><code>        &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;April 1, 2026&lt;/td&gt;</code></p><p><code>816</code><code>      &lt;/tr&gt;</code></p><p><code>817</code><code>            &lt;/tbody&gt;</code></p><p><code>818</code><code>    &lt;/table&gt;</code></p><p><code>819</code><code>          </code></p><p><code>820</code><code>    &lt;!-- NLM links --&gt;</code></p><p><code>821</code><code>&lt;p&gt;</code></p><p><code>822</code><code>&lt;div class="tr-indent2"&gt;</code></p><p><code>823</code><code>  &lt;div class="usa-alert usa-alert-warning nlm-info"&gt;</code></p><p><code>824</code><code>    &lt;strong&gt;Resource links provided by the National Library of Medicine&lt;/strong&gt;</code></p><p><code>825</code><code>    &lt;img src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;" alt=""/&gt;</code></p><p><code>826</code><code>    &lt;p&gt;</code></p><p><code>827</code><code>    &lt;p&gt;</code></p><p><code>828</code><code>          </code></p><p><code>829</code><code>  </code></p><p><code>830</code><code>    &lt;!-- medline links --&gt;</code></p><p><code>831</code><code>  &lt;div style="margin-bottom:2ex;"&gt;</code></p><p><code>832</code><code>    &lt;a class="tr-study-link" href="https://medlineplus.gov/" title="MedlinePlus" onclick="openNewWindow('https://medlineplus.gov/'); return false"&gt;MedlinePlus&lt;/a&gt; related topics:</code></p><p><code>833</code><code>    	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://medlineplus.gov/acutemyeloidleukemia.html" title="Acute&amp;#160;Myeloid&amp;#160;Leukemia at MedlinePlus" onclick="openNewWindow('https://medlineplus.gov/acutemyeloidleukemia.html'); return false"&gt;Acute&amp;#160;Myeloid&amp;#160;Leukemia&lt;/a&gt;</code></p><p><code>834</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://medlineplus.gov/leukemia.html" title="Leukemia at MedlinePlus" onclick="openNewWindow('https://medlineplus.gov/leukemia.html'); return false"&gt;Leukemia&lt;/a&gt;</code></p><p><code>835</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://medlineplus.gov/myelodysplasticsyndromes.html" title="Myelodysplastic&amp;#160;Syndromes at MedlinePlus" onclick="openNewWindow('https://medlineplus.gov/myelodysplasticsyndromes.html'); return false"&gt;Myelodysplastic&amp;#160;Syndromes&lt;/a&gt;</code></p><p><code>836</code><code>	          &lt;/div&gt;</code></p><p><code>837</code><code>  </code></p><p><code>838</code><code>    &lt;!-- SIS links --&gt;</code></p><p><code>839</code><code>  &lt;div style="margin-bottom:2ex;"&gt;</code></p><p><code>840</code><code>    &lt;a class="tr-study-link" href="https://dailymed.nlm.nih.gov/dailymed/" title="Dailymed Portal" onclick="openNewWindow('https://dailymed.nlm.nih.gov/dailymed/'); return false"&gt;Drug Information&lt;/a&gt; </code></p><p><code>841</code><code>          </code></p><p><code>842</code><code>                                          available for:</code></p><p><code>843</code><code>    </code></p><p><code>844</code><code>    	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&amp;query=Venetoclax" title="Venetoclax at Dailymed Portal" onclick="openNewWindow('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&amp;query=Venetoclax'); return false"&gt;Venetoclax&lt;/a&gt;</code></p><p><code>845</code><code>	          &lt;/div&gt;</code></p><p><code>846</code><code>      					      </code></p><p><code>847</code><code>    &lt;!-- ORD links --&gt;</code></p><p><code>848</code><code>  &lt;div style="margin-bottom:2ex;"&gt;</code></p><p><code>849</code><code>    &lt;a class="tr-study-link" href="https://rarediseases.info.nih.gov/gard" title="Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/gard'); return false"&gt;Genetic and Rare Diseases Information Center&lt;/a&gt; resources:</code></p><p><code>850</code><code>    	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/6544/acute-graft-versus-host-disease" title="Acute&amp;#160;Graft&amp;#160;Versus&amp;#160;Host&amp;#160;Disease at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/6544/acute-graft-versus-host-disease'); return false"&gt;Acute&amp;#160;Graft&amp;#160;Versus&amp;#160;Host&amp;#160;Disease&lt;/a&gt;</code></p><p><code>851</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/8226/myeloid-leukemia" title="Myeloid&amp;#160;Leukemia at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/8226/myeloid-leukemia'); return false"&gt;Myeloid&amp;#160;Leukemia&lt;/a&gt;</code></p><p><code>852</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/12757/acute-myeloid-leukemia" title="Acute&amp;#160;Myeloid&amp;#160;Leukemia at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/12757/acute-myeloid-leukemia'); return false"&gt;Acute&amp;#160;Myeloid&amp;#160;Leukemia&lt;/a&gt;</code></p><p><code>853</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/537/acute-non-lymphoblastic-leukemia" title="Acute&amp;#160;Non&amp;#160;Lymphoblastic&amp;#160;Leukemia at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/537/acute-non-lymphoblastic-leukemia'); return false"&gt;Acute&amp;#160;Non&amp;#160;Lymphoblastic&amp;#160;Leukemia&lt;/a&gt;</code></p><p><code>854</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/7132/myelodysplastic-syndromes" title="Myelodysplastic&amp;#160;Syndromes at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/7132/myelodysplastic-syndromes'); return false"&gt;Myelodysplastic&amp;#160;Syndromes&lt;/a&gt;</code></p><p><code>855</code><code>	          &lt;/div&gt;</code></p><p><code>856</code><code>  </code></p><p><code>857</code><code>  </code></p><p><code>858</code><code>  &lt;!-- Ropr Link --&gt;</code></p><p><code>859</code><code>&lt;!-- Commented out RoPR</code></p><p><code>860</code><code>  --&gt;</code></p><p><code>861</code><code>          </code></p><p><code>862</code><code>  &lt;div style="margin-bottom:2ex;"&gt;</code></p><p><code>863</code><code>  &lt;a class="tr-study-link" href="/ct2/info/fdalinks" title="Show FDA resources page" onclick="openNewWindow('/ct2/info/fdalinks'); return false"&gt;U.S. FDA Resources&lt;/a&gt;</code></p><p><code>864</code><code>  &lt;/div&gt;</code></p><p><code>865</code><code>          </code></p><p><code>866</code><code>  &lt;/div&gt;</code></p><p><code>867</code><code>&lt;/div&gt;</code></p><p><code>868</code><code>          </code></p><p><code>869</code><code>          </code></p><p><code>870</code><code>  </code></p><p><code>871</code><code>  &lt;br/&gt;</code></p><p><code>872</code><code>    &lt;/div&gt;</code></p><p><code>873</code><code>          </code></p><p><code>874</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>875</code><code>    		&lt;div class="tr-subsection"&gt;</code></p><p><code>876</code><code>		    		    	&lt;div class="ct-header2"&gt;&lt;a id="armgroup"&gt;&lt;/a&gt;Arms and Interventions&lt;/div&gt;</code></p><p><code>877</code><code>		    		    &lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>878</code><code>			&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>879</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>880</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>881</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>882</code><code>&lt;/button&gt;</code></p><p><code>883</code><code>          </code></p><p><code>884</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>885</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>886</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>887</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>888</code><code>          </code></p><p><code>889</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>890</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>891</code><code>    </code></p><p><code>892</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>893</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>894</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>895</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>896</code><code>  &lt;/div&gt;</code></p><p><code>897</code><code>&lt;/div&gt;</code></p><p><code>898</code><code>		&lt;/div&gt;</code></p><p><code>899</code><code>	</code></p><p><code>900</code><code>    &lt;div style="padding-left:.8em; padding-right:1.2em;text-align:left;"&gt;</code></p><p><code>901</code><code>        &lt;p&gt;</code></p><p><code>902</code><code>    &lt;table class="ct-data_table tr-data_table" style="padding:5px;width:100%;border-width:1px;"&gt;</code></p><p><code>903</code><code>      &lt;thead&gt;</code></p><p><code>904</code><code>      &lt;tr style="text-align:left;"&gt;</code></p><p><code>905</code><code>        &lt;th class="ct-header3 tr-pale_banner_color" style="width:50%;"&gt;</code></p><p><code>906</code><code>            				&lt;span style="display:inline;" class="term" data-term="Arm" title="Show definition"&gt;Arm &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Arm" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; 			        &lt;/th&gt;</code></p><p><code>907</code><code>                &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>908</code><code>			&lt;span style="display:inline;" class="term" data-term="Intervention/treatment" title="Show definition"&gt;Intervention/treatment &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Intervention/treatment" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;         &lt;/th&gt;</code></p><p><code>909</code><code>              &lt;/tr&gt;</code></p><p><code>910</code><code>      &lt;/thead&gt;</code></p><p><code>911</code><code>      &lt;tbody&gt;</code></p><p><code>912</code><code>            &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>913</code><code>        &lt;td class="ct-body3"&gt;</code></p><p><code>914</code><code>          Experimental: Emavusertib (CA-4948) dose escalation</code></p><p><code>915</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Patients receive emavusertib monotherapy BID daily. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.&lt;/div&gt;</code></p><p><code>916</code><code>        &lt;/td&gt;</code></p><p><code>917</code><code>                &lt;td class="ct-body3"&gt;</code></p><p><code>918</code><code>                      Drug: Emavusertib</code></p><p><code>919</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Emavusertib is formulated as a tablet for oral administration for BID dosing in consecutive 28-day cycles. Emavusertib is a novel small molecule inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4). IRAK4 kinase plays an essential role in toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) signaling pathways and these pathways are frequently dysregulated in non-Hodgkin's lymphoma and AML/MDS malignancies.&lt;/div&gt;</code></p><p><code>920</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Name: CA-4948&lt;/div&gt;&lt;br/&gt;</code></p><p><code>921</code><code>                  &lt;/td&gt;</code></p><p><code>922</code><code>              &lt;/tr&gt;</code></p><p><code>923</code><code>            &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>924</code><code>        &lt;td class="ct-body3"&gt;</code></p><p><code>925</code><code>          Experimental: Emavusertib dose escalation + Venetoclax</code></p><p><code>926</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;&lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;The starting dose for emavusertib will be 200 mg BID for 21 days of a 28-day Cycle. Anticipated emavusertib doses will be 200 and 300 mg BID. Venetoclax will be administered at 100 mg orally (Day 1) per the product label at the same time each day with a ramp up over 3 days to 400 mg for 21days of a 28-day Cycle. Second and subsequent cycles start with target dose level.&lt;/p&gt;</code></p><p><code>927</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;This arm of the study has been closed to enrollment.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>928</code><code>        &lt;/td&gt;</code></p><p><code>929</code><code>                &lt;td class="ct-body3"&gt;</code></p><p><code>930</code><code>                      Drug: Venetoclax</code></p><p><code>931</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Ventoclax is B-cell lymphoma-2 (BCL-2) inhibitor. Venetoclax will be administered at 100 mg orally (Day 1) per the product label at the same time each day with a ramp up over 3 days to 400 mg for 21days of a 28-day Cycle. Second and subsequent cycles start with target dose level.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>932</code><code>                      Drug: Emavusertib</code></p><p><code>933</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Emavusertib is formulated as a tablet for oral administration for BID dosing for 21 days (Days 1-21) of a 28-day Cycle.&lt;/div&gt;</code></p><p><code>934</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Name: CA-4948&lt;/div&gt;&lt;br/&gt;</code></p><p><code>935</code><code>                  &lt;/td&gt;</code></p><p><code>936</code><code>              &lt;/tr&gt;</code></p><p><code>937</code><code>            &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>938</code><code>        &lt;td class="ct-body3"&gt;</code></p><p><code>939</code><code>          Experimental: Emavusertib monotherapy dose expansion</code></p><p><code>940</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;The Expansion phase will begin once the RP2D from Phase 1 Dose Escalation phase has been identified. There will be 3 Cohorts and patients will be assigned to each Cohort based on baseline disease.&lt;/div&gt;</code></p><p><code>941</code><code>        &lt;/td&gt;</code></p><p><code>942</code><code>                &lt;td class="ct-body3"&gt;</code></p><p><code>943</code><code>                      Drug: Emavusertib</code></p><p><code>944</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Emavusertib is formulated as a tablet for oral administration for BID dosing in consecutive 28-day cycles. Emavusertib is a novel small molecule inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4). IRAK4 kinase plays an essential role in toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) signaling pathways and these pathways are frequently dysregulated in non-Hodgkin's lymphoma and AML/MDS malignancies.&lt;/div&gt;</code></p><p><code>945</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Name: CA-4948&lt;/div&gt;&lt;br/&gt;</code></p><p><code>946</code><code>                  &lt;/td&gt;</code></p><p><code>947</code><code>              &lt;/tr&gt;</code></p><p><code>948</code><code>            &lt;/tbody&gt;</code></p><p><code>949</code><code>    &lt;/table&gt;</code></p><p><code>950</code><code>          &lt;/div&gt;</code></p><p><code>951</code><code>    &lt;br/&gt;</code></p><p><code>952</code><code>          </code></p><p><code>953</code><code>    </code></p><p><code>954</code><code>    &lt;!-- more details --&gt;</code></p><p><code>955</code><code>  &lt;br/&gt;</code></p><p><code>956</code><code>  &lt;div class="tr-subsection"&gt;</code></p><p><code>957</code><code>	  &lt;div class="ct-header2"&gt;&lt;a id="outcomemeasures"&gt;&lt;/a&gt;Outcome Measures&lt;/div&gt;</code></p><p><code>958</code><code>	  &lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>959</code><code>	  &lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>960</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>961</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>962</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>963</code><code>&lt;/button&gt;</code></p><p><code>964</code><code>          </code></p><p><code>965</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>966</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>967</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>968</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>969</code><code>          </code></p><p><code>970</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>971</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>972</code><code>    </code></p><p><code>973</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>974</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>975</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>976</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>977</code><code>  &lt;/div&gt;</code></p><p><code>978</code><code>&lt;/div&gt;</code></p><p><code>979</code><code>  &lt;/div&gt;</code></p><p><code>980</code><code>  &lt;br/&gt;</code></p><p><code>981</code><code>  &lt;div class="tr-indent3" style="margin-right:1em;"&gt;</code></p><p><code>982</code><code>          </code></p><p><code>983</code><code>        &lt;!-- primary outcomes --&gt;</code></p><p><code>984</code><code>    &lt;div class="ct-body3"&gt;</code></p><p><code>985</code><code>&lt;span style="display:inline;" class="term" data-term="Primary Outcome Measure" title="Show definition"&gt;Primary Outcome Measures &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Primary Outcome Measure" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :</code></p><p><code>986</code><code>      &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>987</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Determine Maximum Tolerated Dose (MTD) of emavusertib (CA-4948) monotherapy (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;28 days&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;The highest dose at which there is &amp;lt;33% Dose Limiting Toxicity rate in the first cycle of treatment in a minimum of 6 patients.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>988</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Determine the Recommended Phase 2 Dose (RP2D) of emavusertib monotherapy (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;The RP2D will be determined by the Clinical Safety Committee (CSC) in consultation with the Sponsor, considering all aspects of safety, tolerability, biologic activity, pharmacokinetics and preliminary efficacy in the trial population. The intent of an RP2D is to provide a dose and schedule that will maximize the opportunity for clinical benefit, while minimizing the risk of toxicity.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>989</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Determine Maximum Tolerated Dose (MTD) of emavusertib in combination with venetoclax (Phase 1b) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;28 days&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;The highest dose at which there is &amp;lt;33% Dose Limiting Toxicity rate in the first cycle of treatment in a minimum of 6 patients.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>990</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Determine the Recommended Phase 2 Dose (RP2D) of emavusertib in combination with venetoclax (Phase 1b) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;The RP2D will be determined by the Clinical Safety Committee (CSC) in consultation with the Sponsor, considering all aspects of safety, tolerability, biologic activity, pharmacokinetics and preliminary efficacy in the trial population. The intent of an RP2D is to provide a dose and schedule that will maximize the opportunity for clinical benefit, while minimizing the risk of toxicity.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>991</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;To assess anti-cancer activity (Phase 2a - AML patients) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Proportion of patients who achieve CR + CRh&lt;/div&gt;&lt;br/&gt;</code></p><p><code>992</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;To assess anti-cancer activity (Phase 2a - hrMDS patients) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Overall response rate: proportion of patients who achieve CR+PR&lt;/div&gt;&lt;br/&gt;</code></p><p><code>993</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;To assess safety (Phase 1b) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Clinical safety assessments including frequency of adverse events (AEs)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>994</code><code>            &lt;/ol&gt;</code></p><p><code>995</code><code>    &lt;/div&gt;</code></p><p><code>996</code><code>    &lt;br/&gt;</code></p><p><code>997</code><code>    </code></p><p><code>998</code><code>        &lt;!-- secondary outcomes --&gt;</code></p><p><code>999</code><code>    &lt;div class="ct-body3"  style="margin-right:1em;"&gt;</code></p><p><code>1000</code><code>&lt;span style="display:inline;" class="term" data-term="Secondary Outcome Measure" title="Show definition"&gt;Secondary Outcome Measures &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Secondary Outcome Measure" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :</code></p><p><code>1001</code><code>      &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1002</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To characterize the pharmacokinetic (PK) parameters of emavusertib measured by Cmax (Phase 1 and 1b) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;maximum plasma concentration (Cmax)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1003</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To characterize the pharmacokinetic (PK) parameters of emavusertib measured by Cmin (Phase 1 and Phase 1b) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;trough plasma concentration (Cmin)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1004</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To characterize the pharmacokinetic (PK) parameters of emavusertib measured by Tmax (Phase 1 and 1b) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Time to maximum plasma concentration&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1005</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To characterize the pharmacokinetic (PK) parameters of emavusertib measured by Area under the plasma concentration versus time curve(AUC) [0-24] (Phase 1 and 1b) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Area under the plasma concentration-time curve from 0 to 24 hours&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1006</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To characterize the pharmacokinetic (PK) parameters of emavusertib measured by AUC[INF] (Phase 1 and 1b) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Area under the plasma concentration-time curve from 0 to infinity&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1007</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To characterize the pharmacokinetic (PK) parameters of emavusertib measured by T 1/2 (Phase 1 and 1b) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Plasma terminal elimination half-life (T 1/2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1008</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To assess clinical response (Phase 1 and 1b) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;For AML: assessed by proportion of patients who reach complete response (CR) + complete response with partial hematological recovery (CRh) assessed by proportion of patients who reach complete response with incomplete hematologic recovery (CRi) or CR or Crh For hrMDS: overall response rate of CR+partial response (PR)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1009</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To assess clinical response (Phase 1 and 1b) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by transfusion independence&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1010</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To assess tolerability and long term safety (Phase 2a) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Clinical safety assessments including frequency of adverse events (AEs)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1011</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To assess clinical response (Phase 2a) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;For AML - assessed by proportion of patients who achieve CR or CRh or CRi; For hrMDS - assessed by proportion of patients who achieve CR or PR or mCR&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1012</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To assess clinical response (Phase 2a) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by duration of response (DOR)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1013</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To assess clinical response (Phase 2a) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by time to response&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1014</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To assess clinical response (Phase 2a) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by transfusion independence&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1015</code><code>            &lt;li style="margin-top:0.7ex;"&gt;To assess clinical response (Phase 2a) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;24 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by overall survival (OS)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1016</code><code>            &lt;/ol&gt;</code></p><p><code>1017</code><code>    &lt;/div&gt;</code></p><p><code>1018</code><code>    &lt;br/&gt;</code></p><p><code>1019</code><code>    </code></p><p><code>1020</code><code>    </code></p><p><code>1021</code><code>    </code></p><p><code>1022</code><code>  &lt;/div&gt;</code></p><p><code>1023</code><code>  </code></p><p><code>1024</code><code>			  </code></p><p><code>1025</code><code>&lt;!-- eligibility_section --&gt;</code></p><p><code>1026</code><code>&lt;div class="tr-indent1" style="margin-top:3ex; border:1px solid white"&gt;</code></p><p><code>1027</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>1028</code><code>	&lt;div class="ct-header2"&gt;&lt;a id="eligibility"&gt;&lt;/a&gt;Eligibility Criteria&lt;/div&gt;</code></p><p><code>1029</code><code>	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>1030</code><code>	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>1031</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>1032</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>1033</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>1034</code><code>&lt;/button&gt;</code></p><p><code>1035</code><code>          </code></p><p><code>1036</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>1037</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>1038</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>1039</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>1040</code><code>          </code></p><p><code>1041</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>1042</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>1043</code><code>    </code></p><p><code>1044</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>1045</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>1046</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>1047</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>1048</code><code>  &lt;/div&gt;</code></p><p><code>1049</code><code>&lt;/div&gt;</code></p><p><code>1050</code><code>&lt;/div&gt;</code></p><p><code>1051</code><code>&lt;br/&gt;</code></p><p><code>1052</code><code>          </code></p><p><code>1053</code><code>&lt;p&gt;</code></p><p><code>1054</code><code>  &lt;div class="tr-indent2 usa-alert usa-alert-warning nlm-info"&gt;</code></p><p><code>1055</code><code>    &lt;strong&gt;Information from the National Library of Medicine&lt;/strong&gt;</code></p><p><code>1056</code><code>    &lt;img src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;" alt=""/&gt;</code></p><p><code>1057</code><code>    &lt;p&gt;</code></p><p><code>1058</code><code>    &lt;p&gt;</code></p><p><code>1059</code><code>    &lt;em&gt;Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, &lt;a href="/ct2/about-studies/learn" title="Learn About Clinical Studies"&gt;&lt;u&gt;Learn About Clinical Studies.&lt;/u&gt;&lt;/a&gt;</code></p><p><code>1060</code><code>    &lt;/em&gt;</code></p><p><code>1061</code><code>  &lt;/div&gt;</code></p><p><code>1062</code><code>          </code></p><p><code>1063</code><code>          </code></p><p><code>1064</code><code>  &lt;br/&gt;</code></p><p><code>1065</code><code>  &lt;div class="tr-indent2"&gt;</code></p><p><code>1066</code><code>    &lt;table class="ct-layout_table tr-tableStyle tr-studyInfo"&gt;</code></p><p><code>1067</code><code>      &lt;caption&gt;Layout table for eligibility information&lt;/caption&gt;</code></p><p><code>1068</code><code>      &lt;thead&gt;</code></p><p><code>1069</code><code>        &lt;tr&gt;</code></p><p><code>1070</code><code>          &lt;th id="elgType"&gt;&lt;/th&gt;</code></p><p><code>1071</code><code>          &lt;th id="elgData"&gt;&lt;/th&gt;</code></p><p><code>1072</code><code>        &lt;/tr&gt;</code></p><p><code>1073</code><code>      &lt;/thead&gt;</code></p><p><code>1074</code><code>      &lt;tbody&gt;</code></p><p><code>1075</code><code>            &lt;tr&gt;</code></p><p><code>1076</code><code>        &lt;td headers="elgType" class="ct-nowrap"&gt;Ages Eligible for Study: &amp;nbsp; &lt;/td&gt;</code></p><p><code>1077</code><code>        &lt;td headers="elgData" style="padding-left:1em"&gt;18 Years and older &amp;nbsp; (Adult, Older Adult)&lt;/td&gt;</code></p><p><code>1078</code><code>      &lt;/tr&gt;</code></p><p><code>1079</code><code>                  &lt;tr&gt;</code></p><p><code>1080</code><code>        &lt;td headers="elgType" class="ct-nowrap"&gt;Sexes Eligible for Study: &amp;nbsp; &lt;/td&gt;</code></p><p><code>1081</code><code>        &lt;td headers="elgData" style="padding-left:1em"&gt;All&lt;/td&gt;</code></p><p><code>1082</code><code>      &lt;/tr&gt;</code></p><p><code>1083</code><code>                              &lt;tr&gt;</code></p><p><code>1084</code><code>        &lt;td headers="elgType" class="ct-nowrap"&gt;Accepts Healthy Volunteers: &amp;nbsp; &lt;/td&gt;</code></p><p><code>1085</code><code>        &lt;td headers="elgData" style="padding-left:1em"&gt;No&lt;/td&gt;</code></p><p><code>1086</code><code>      &lt;/tr&gt;</code></p><p><code>1087</code><code>                  &lt;/tbody&gt;</code></p><p><code>1088</code><code>    &lt;/table&gt;</code></p><p><code>1089</code><code>          </code></p><p><code>1090</code><code>    </code></p><p><code>1091</code><code>        &lt;div class="ct-header3" style="margin-top:2ex"&gt;Criteria&lt;/div&gt;</code></p><p><code>1092</code><code>    &lt;div class="tr-indent2"&gt;&lt;p style="margin-top:1ex; margin-bottom:1ex;"&gt;Inclusion Criteria:&lt;/p&gt;</code></p><p><code>1093</code><code>  &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1094</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Males and females &amp;#8805;18 years of age&lt;/li&gt;</code></p><p><code>1095</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Life expectancy of at least 3 months&lt;/li&gt;</code></p><p><code>1096</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Eastern Cooperative Oncology Group (ECOG) Performance Status of &amp;#8804;1&lt;/li&gt;</code></p><p><code>1097</code><code>    &lt;li style="margin-top:0.7ex;"&gt;</code></p><p><code>1098</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cytomorphology based confirmed diagnosis of MDS or AML (as per WHO 2016 classification) with the following characteristics.&lt;/p&gt;</code></p><p><code>1099</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Phase 1 Dose Escalation (Monotherapy)&lt;/p&gt;</code></p><p><code>1100</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;&amp;#8226; AML (primary or secondary, including treatment-related) after failing at least 1 standard treatment (may include chemotherapy, re induction therapy or stem cell transplantation).&lt;/p&gt;</code></p><p><code>1101</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;OR&lt;/p&gt;</code></p><p><code>1102</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;&amp;#8226; Higher-risk R/R MDS that are considered resistant/refractory following at least 2 to 3 cycles of hypermethylating agent (HMA) or evidence of early progression&lt;/p&gt;</code></p><p><code>1103</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Phase 2a Dose Expansion (Monotherapy)&lt;/p&gt;</code></p><p><code>1104</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Patients with:&lt;/p&gt;</code></p><p><code>1105</code><code>      &lt;ul style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1106</code><code>        &lt;li style="margin-top:0.7ex;"&gt;R/R AMLwith FLT3 mutations who have been previously treated with a FLT3 inhibitor&lt;/li&gt;</code></p><p><code>1107</code><code>        &lt;li style="margin-top:0.7ex;"&gt;R/R AML with spliceosome mutations of SF3B1 or U2AF1&lt;/li&gt;</code></p><p><code>1108</code><code>        &lt;li style="margin-top:0.7ex;"&gt;R/R hrMDS (IPSS-R score &amp;gt; 3.5) with spliceosome mutations of SF3B1 or U2AF1&lt;/li&gt;</code></p><p><code>1109</code><code>        &lt;li style="margin-top:0.7ex;"&gt;Number of pretreatments: 1 or 2&lt;/li&gt;</code></p><p><code>1110</code><code>      &lt;/ul&gt;</code></p><p><code>1111</code><code>    &lt;/li&gt;</code></p><p><code>1112</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Acceptable organ function at screening&lt;/li&gt;</code></p><p><code>1113</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Ability to swallow and retain oral medications&lt;/li&gt;</code></p><p><code>1114</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Negative serum pregnancy test in women of childbearing potential&lt;/li&gt;</code></p><p><code>1115</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Women of childbearing potential and men who partner with a woman of childbearing potential must agree to use highly effective contraceptive methods for the duration of the study and for 90 days after the last dose of emavusertib&lt;/li&gt;</code></p><p><code>1116</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Willing and able to provide written informed consent and comply with the requirements of the trial&lt;/li&gt;</code></p><p><code>1117</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Able to undergo serial bone marrow sampling and peripheral blood sampling&lt;/li&gt;</code></p><p><code>1118</code><code>  &lt;/ol&gt;</code></p><p><code>1119</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Exclusion Criteria:&lt;/p&gt;</code></p><p><code>1120</code><code>  &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1121</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Diagnosed with acute promyelocytic leukemia (APL, M3)&lt;/li&gt;</code></p><p><code>1122</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Has known active central nervous system (CNS) leukemia&lt;/li&gt;</code></p><p><code>1123</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Allogeneic hematopoietic stem cell transplant (Allo-HSCT) within 60 days of the first dose of emavusertib, or clinically significant graft-versus-host disease (GVHD) requiring ongoing up titration of immunosuppressive medications prior to start of emavusertib&lt;/li&gt;</code></p><p><code>1124</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Chronic myeloid leukemia (CML)&lt;/li&gt;</code></p><p><code>1125</code><code>    &lt;li style="margin-top:0.7ex;"&gt;</code></p><p><code>1126</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Any prior systemic anti-cancer treatment such as chemotherapy, immunomodulatory drug therapy, etc., received within 3 weeks (or 5 half-lives) prior to start of emavusertib.&lt;/p&gt;</code></p><p><code>1127</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Localized radiation or surgical resection of skin cancers allowed.&lt;/p&gt;</code></p><p><code>1128</code><code>    &lt;/li&gt;</code></p><p><code>1129</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Use of any investigational agent within 3 weeks or 5 half-lives, whichever is shorter, prior to start of emavusertib&lt;/li&gt;</code></p><p><code>1130</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Presence of an acute or chronic toxicity resulting from prior anti-cancer therapy, with the exception of alopecia that has not resolved to Grade &amp;#8804; 1within 7 days prior to start of emavusertib; presence of any acute or chronic non-hematological toxicity &amp;#8805; Grade 3 at Screening, or prior to start of emavusertib must resolve to &amp;#8804; Grade 2.&lt;/li&gt;</code></p><p><code>1131</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Known allergy or hypersensitivity to any component of the formulation of emavusertib&lt;/li&gt;</code></p><p><code>1132</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Major surgery, other than diagnostic surgery, &amp;lt;28 days from the start of emavusertib; minor surgery &amp;lt;14 days from the start of emavusertib&lt;/li&gt;</code></p><p><code>1133</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Patients with active advanced malignant solid tumors&lt;/li&gt;</code></p><p><code>1134</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Known to be human immunodeficiency virus (HIV) positive or have an acquired immunodeficiency syndrome-related illness&lt;/li&gt;</code></p><p><code>1135</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Hepatitis B virus (HBV) DNA positive or Hepatitis C virus (HCV) infection &amp;lt;6 months prior to start of emavusertib unless viral load is undetectable, or HCV with cirrhosis&lt;/li&gt;</code></p><p><code>1136</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Uncontrolled or severe cardiovascular diseaseincluding myocardial infarction or unstable angina within 6 months prior to CA-4948, New York Heart Association Class II or greater congestive heart failure, or left ventricular ejection fraction &amp;lt; 40% by echocardiogram or multi-gated acquisition scan, serious arrhythmias uncontrolled on treatment, clinically significant pericardial disease, cardiac amyloidosis, congenital long QT syndrome, or QTc with Fridericia's correction (QTcF) that is unmeasurable or &amp;gt; 450 msec on Screening electrocardiogram (ECG)&lt;/li&gt;</code></p><p><code>1137</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Gastrointestinal disease or disorder that could interfere with the swallowing, oral absorption, or tolerance of emavusertib&lt;/li&gt;</code></p><p><code>1138</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Pregnant or lactating&lt;/li&gt;</code></p><p><code>1139</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Systemic fungal, bacterial, viral, or other infection that is not controlled&lt;/li&gt;</code></p><p><code>1140</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Any other severe, acute, or chronic medical, psychiatric or social condition, or laboratory abnormality that may increase the risk of trial participation or emavusertib administration&lt;/li&gt;</code></p><p><code>1141</code><code>  &lt;/ol&gt;&lt;/div&gt;</code></p><p><code>1142</code><code>    </code></p><p><code>1143</code><code>  &lt;/div&gt;</code></p><p><code>1144</code><code>          </code></p><p><code>1145</code><code>  &lt;/div&gt;</code></p><p><code>1146</code><code>          </code></p><p><code>1147</code><code>			  </code></p><p><code>1148</code><code>&lt;!-- location_section --&gt;</code></p><p><code>1149</code><code>&lt;a id="contacts"&gt;&lt;/a&gt;</code></p><p><code>1150</code><code>&lt;div class="tr-indent1" style="margin-top:3ex"&gt;</code></p><p><code>1151</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>1152</code><code>	&lt;div class="ct-header2"&gt;&lt;a id="contactlocation"&gt;&lt;/a&gt;Contacts and Locations&lt;/div&gt;</code></p><p><code>1153</code><code>	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>1154</code><code>	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>1155</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>1156</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>1157</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>1158</code><code>&lt;/button&gt;</code></p><p><code>1159</code><code>          </code></p><p><code>1160</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>1161</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>1162</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>1163</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>1164</code><code>          </code></p><p><code>1165</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>1166</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>1167</code><code>    </code></p><p><code>1168</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>1169</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>1170</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>1171</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>1172</code><code>  &lt;/div&gt;</code></p><p><code>1173</code><code>&lt;/div&gt;</code></p><p><code>1174</code><code>&lt;/div&gt;</code></p><p><code>1175</code><code>&lt;br/&gt;</code></p><p><code>1176</code><code>          </code></p><p><code>1177</code><code>          </code></p><p><code>1178</code><code>&lt;div class="tr-indent2" style="margin-top:2ex"&gt;</code></p><p><code>1179</code><code>          </code></p><p><code>1180</code><code>&lt;!--</code></p><p><code>1181</code><code>Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. </code></p><p><code>1182</code><code>To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. </code></p><p><code>1183</code><code>For general information, see &lt;a href="/ct2/about-studies/learn" target="def_win" onClick="openNewWindow('/ct2/about-studies/learn'); return false;" title="Learn About Clinical Studies - opens new window"&gt;&lt;u&gt;Learn About Clinical Studies.&lt;/u&gt;&lt;/a&gt;</code></p><p><code>1184</code><code>&lt;br/&gt;</code></p><p><code>1185</code><code>--&gt;</code></p><p><code>1186</code><code>          </code></p><p><code>1187</code><code>  </code></p><p><code>1188</code><code>  &lt;div class="usa-alert usa-alert-warning nlm-info"&gt;</code></p><p><code>1189</code><code>    &lt;strong&gt;Information from the National Library of Medicine&lt;/strong&gt;</code></p><p><code>1190</code><code>    &lt;img src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;" alt=""/&gt;</code></p><p><code>1191</code><code>    &lt;p&gt;</code></p><p><code>1192</code><code>    &lt;p&gt;</code></p><p><code>1193</code><code>    &lt;em&gt;</code></p><p><code>1194</code><code>    To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.</code></p><p><code>1195</code><code>    &lt;/em&gt;</code></p><p><code>1196</code><code>    &lt;p&gt;</code></p><p><code>1197</code><code>    &lt;em&gt;</code></p><p><code>1198</code><code>    Please refer to this study by its ClinicalTrials.gov identifier (NCT number): &lt;strong&gt;NCT04278768&lt;/strong&gt;</code></p><p><code>1199</code><code>    &lt;/em&gt;</code></p><p><code>1200</code><code>  &lt;/div&gt;</code></p><p><code>1201</code><code>  &lt;br/&gt;</code></p><p><code>1202</code><code>          </code></p><p><code>1203</code><code>  &lt;!-- contacts --&gt;</code></p><p><code>1204</code><code>    &lt;div class="ct-header3" style="margin-top:2ex"&gt;Contacts&lt;/div&gt;</code></p><p><code>1205</code><code>  &lt;div class="tr-table_cover"&gt;</code></p><p><code>1206</code><code>    &lt;table class="ct-layout_table tr-indent2"&gt;</code></p><p><code>1207</code><code>      &lt;caption&gt;Layout table for location contacts&lt;/caption&gt;</code></p><p><code>1208</code><code>    &lt;thead&gt;</code></p><p><code>1209</code><code>    &lt;tr&gt;</code></p><p><code>1210</code><code>      &lt;th id="contactName" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1211</code><code>      &lt;th id="contactPhone" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1212</code><code>      &lt;th id="contactEmail" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1213</code><code>      &lt;th id="contactAddress" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1214</code><code>    &lt;/tr&gt;</code></p><p><code>1215</code><code>    &lt;/thead&gt;</code></p><p><code>1216</code><code>        &lt;tr&gt;</code></p><p><code>1217</code><code>      &lt;td headers="contactName"&gt;Contact: Reinhard von Roemeling, MD&lt;/td&gt;</code></p><p><code>1218</code><code>            &lt;td headers="contactPhone"&gt;617-503-6500&lt;/td&gt;</code></p><p><code>1219</code><code>                  &lt;td headers="contactEmail"&gt;&lt;a href="mailto:clinicaltrials%40curis.com?subject=NCT04278768, CA-4948-102, Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With AML or MDS"&gt;clinicaltrials@curis.com&lt;/a&gt;&lt;/td&gt;</code></p><p><code>1220</code><code>                  &lt;td headers="contactAddress"&gt;&lt;/td&gt;</code></p><p><code>1221</code><code>          &lt;/tr&gt;</code></p><p><code>1222</code><code>      &lt;/table&gt;</code></p><p><code>1223</code><code>  &lt;/div&gt;</code></p><p><code>1224</code><code>  &lt;br/&gt;</code></p><p><code>1225</code><code>  </code></p><p><code>1226</code><code>  &lt;!-- locations --&gt;</code></p><p><code>1227</code><code>   &lt;a id="locn"&gt;&lt;/a&gt;</code></p><p><code>1228</code><code>  &lt;div class="ct-header3" style="margin-top:2ex;margin-bottom:2ex;"&gt;Locations&lt;/div&gt;</code></p><p><code>1229</code><code>          </code></p><p><code>1230</code><code>      &lt;script type="text/javascript" async src="/ct2/html/js/ExpandCollapseScript.js"&gt;&lt;/script&gt;</code></p><p><code>1231</code><code>    </code></p><p><code>1232</code><code>    &lt;span id="EXPAND_CONTROL-Locations" class="EXPAND tr-showAndHide"       onclick="toggleSectionAndControls('-Locations');document.getElementById('locn').scrollIntoView({behavior: 'smooth', block: 'start'});" </code></p><p><code>1233</code><code>      title="Show 25 study locations"&gt;</code></p><p><code>1234</code><code>      &lt;img src="/ct2/html/images/expand.png" alt="Show"&gt;</code></p><p><code>1235</code><code>      &lt;span style="padding-bottom:3px"&gt; Show 25 study locations&lt;/span&gt;</code></p><p><code>1236</code><code>    &lt;/span&gt;</code></p><p><code>1237</code><code>    &lt;span  id="COLLAPSE_CONTROL-Locations" class="COLLAPSE tr-showAndHide" style="display:none"      onclick="toggleSectionAndControls('-Locations');" </code></p><p><code>1238</code><code>      title="Hide 25 study locations"&gt;</code></p><p><code>1239</code><code>      &lt;img src="/ct2/html/images/collapse.png"  alt="Hide"&gt;</code></p><p><code>1240</code><code>      &lt;span style="padding-bottom:3px"&gt; Hide 25 study locations&lt;/span&gt;</code></p><p><code>1241</code><code>    &lt;/span&gt;</code></p><p><code>1242</code><code>     </code></p><p><code>1243</code><code>  &lt;div id="COLLAPSE-Locations" class="COLLAPSE" style="display:none"&gt;</code></p><p><code>1244</code><code>        &lt;div class="tr-table_cover"&gt;</code></p><p><code>1245</code><code>      &lt;table class="ct-layout_table tr-indent2"&gt;</code></p><p><code>1246</code><code>        &lt;caption&gt;Layout table for location information&lt;/caption&gt;</code></p><p><code>1247</code><code>        &lt;thead&gt;</code></p><p><code>1248</code><code>          &lt;tr&gt;</code></p><p><code>1249</code><code>            &lt;th id="locName"&gt;&lt;/th&gt;</code></p><p><code>1250</code><code>            &lt;th id="locStatus"&gt;&lt;/th&gt;</code></p><p><code>1251</code><code>          &lt;/tr&gt;</code></p><p><code>1252</code><code>        &lt;/thead&gt;</code></p><p><code>1253</code><code>        &lt;tbody&gt;</code></p><p><code>1254</code><code>                                    &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Florida&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1255</code><code>                                      &lt;tr&gt;</code></p><p><code>1256</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Moffitt Cancer Center&lt;/td&gt;</code></p><p><code>1257</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1258</code><code>                          &lt;/tr&gt;</code></p><p><code>1259</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Tampa, Florida, United States, 33612  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1260</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Illinois&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1261</code><code>                                      &lt;tr&gt;</code></p><p><code>1262</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Northwestern Memorial Hospital&lt;/td&gt;</code></p><p><code>1263</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1264</code><code>                          &lt;/tr&gt;</code></p><p><code>1265</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Chicago, Illinois, United States, 60611  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1266</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Massachusetts&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1267</code><code>                                      &lt;tr&gt;</code></p><p><code>1268</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Dana Farber Cancer Institute&lt;/td&gt;</code></p><p><code>1269</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1270</code><code>                          &lt;/tr&gt;</code></p><p><code>1271</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Boston, Massachusetts, United States, 02215  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1272</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Nebraska&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1273</code><code>                                      &lt;tr&gt;</code></p><p><code>1274</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Oncology Hematology West, PC dba Nebraska Cancer Specialists&lt;/td&gt;</code></p><p><code>1275</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1276</code><code>                          &lt;/tr&gt;</code></p><p><code>1277</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Omaha, Nebraska, United States, 68130  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1278</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, New York&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1279</code><code>                                      &lt;tr&gt;</code></p><p><code>1280</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Albert Einstein Medical College&lt;/td&gt;</code></p><p><code>1281</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1282</code><code>                          &lt;/tr&gt;</code></p><p><code>1283</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Bronx, New York, United States, 10461  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1284</code><code>                                                          &lt;tr&gt;</code></p><p><code>1285</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;University of Rochester Medical Center&lt;/td&gt;</code></p><p><code>1286</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1287</code><code>                          &lt;/tr&gt;</code></p><p><code>1288</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Rochester, New York, United States, 14642  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1289</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, North Carolina&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1290</code><code>                                      &lt;tr&gt;</code></p><p><code>1291</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Novant Health Hematology - Forsyth&lt;/td&gt;</code></p><p><code>1292</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1293</code><code>                          &lt;/tr&gt;</code></p><p><code>1294</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Winston-Salem, North Carolina, United States, 27103  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1295</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Texas&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1296</code><code>                                      &lt;tr&gt;</code></p><p><code>1297</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;The University of Texas MD Anderson Cancer Center&lt;/td&gt;</code></p><p><code>1298</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1299</code><code>                          &lt;/tr&gt;</code></p><p><code>1300</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Houston, Texas, United States, 77030  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1301</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;Czechia&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1302</code><code>                                      &lt;tr&gt;</code></p><p><code>1303</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Vseobecna Fakultni nemocnice v Praze&lt;/td&gt;</code></p><p><code>1304</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1305</code><code>                          &lt;/tr&gt;</code></p><p><code>1306</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Praha 2, Czechia, 12 808  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1307</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;France&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1308</code><code>                                      &lt;tr&gt;</code></p><p><code>1309</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Service d'h&amp;#233;matologie clinique CHU de Nic&lt;/td&gt;</code></p><p><code>1310</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1311</code><code>                          &lt;/tr&gt;</code></p><p><code>1312</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Nice, France, 6200  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1313</code><code>                                                          &lt;tr&gt;</code></p><p><code>1314</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;APHP - Sorbonne Universite&lt;/td&gt;</code></p><p><code>1315</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1316</code><code>                          &lt;/tr&gt;</code></p><p><code>1317</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Paris, France, 75012  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1318</code><code>                                                          &lt;tr&gt;</code></p><p><code>1319</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;APHP - Hopital Saint Louis&lt;/td&gt;</code></p><p><code>1320</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1321</code><code>                          &lt;/tr&gt;</code></p><p><code>1322</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Paris, France, 75475  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1323</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;Germany&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1324</code><code>                                      &lt;tr&gt;</code></p><p><code>1325</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Marien Hospital Dusseldorf; Klinik fur Onkologie und Hamatologie, Palliativmedizin&lt;/td&gt;</code></p><p><code>1326</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1327</code><code>                          &lt;/tr&gt;</code></p><p><code>1328</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;D&amp;#252;sseldorf, Germany, 40479  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1329</code><code>                                                          &lt;tr&gt;</code></p><p><code>1330</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Universitatsklinikum Leipzig; Medizinische Klinik und Poliklinik I&lt;/td&gt;</code></p><p><code>1331</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1332</code><code>                          &lt;/tr&gt;</code></p><p><code>1333</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Leipzig, Germany, 04103  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1334</code><code>                                                          &lt;tr&gt;</code></p><p><code>1335</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Klinikum rechts der Isar der Technischen Universitat Munchen&lt;/td&gt;</code></p><p><code>1336</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1337</code><code>                          &lt;/tr&gt;</code></p><p><code>1338</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;M&amp;#252;nchen, Germany, 81675  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1339</code><code>                                                          &lt;tr&gt;</code></p><p><code>1340</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Universitatsklinikum Munster&lt;/td&gt;</code></p><p><code>1341</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1342</code><code>                          &lt;/tr&gt;</code></p><p><code>1343</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;M&amp;#252;nster, Germany, 48149  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1344</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;Israel&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1345</code><code>                                      &lt;tr&gt;</code></p><p><code>1346</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Soroka University MC&lt;/td&gt;</code></p><p><code>1347</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1348</code><code>                          &lt;/tr&gt;</code></p><p><code>1349</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Be'er Sheva, Israel, 84100  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1350</code><code>                                                          &lt;tr&gt;</code></p><p><code>1351</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Edith Wolfson Medical Center&lt;/td&gt;</code></p><p><code>1352</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1353</code><code>                          &lt;/tr&gt;</code></p><p><code>1354</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;H&amp;#817;olon, Israel, 5822012  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1355</code><code>                                                          &lt;tr&gt;</code></p><p><code>1356</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Hadassah University MC&lt;/td&gt;</code></p><p><code>1357</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1358</code><code>                          &lt;/tr&gt;</code></p><p><code>1359</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Jerusalem, Israel, 9112001  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1360</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;Poland&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1361</code><code>                                      &lt;tr&gt;</code></p><p><code>1362</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Uniwersyteckie Centrum Kliniczne Osrodek Badan Klinicznych Wczesnych Faz&lt;/td&gt;</code></p><p><code>1363</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1364</code><code>                          &lt;/tr&gt;</code></p><p><code>1365</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Gda&amp;#324;sk, Poland, 80-214  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1366</code><code>                                                          &lt;tr&gt;</code></p><p><code>1367</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;University Hospital in Krakow&lt;/td&gt;</code></p><p><code>1368</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1369</code><code>                          &lt;/tr&gt;</code></p><p><code>1370</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Krak&amp;#243;w, Poland, 31 501  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1371</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;Spain&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1372</code><code>                                      &lt;tr&gt;</code></p><p><code>1373</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Hospital de la Santa Creu I Sant Pau (Neuvo Hospital)&lt;/td&gt;</code></p><p><code>1374</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1375</code><code>                          &lt;/tr&gt;</code></p><p><code>1376</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Barcelona, Spain  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1377</code><code>                                                          &lt;tr&gt;</code></p><p><code>1378</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Hospital Universitaro del a Princesa&lt;/td&gt;</code></p><p><code>1379</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1380</code><code>                          &lt;/tr&gt;</code></p><p><code>1381</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Madrid, Spain, 28006  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1382</code><code>                                                          &lt;tr&gt;</code></p><p><code>1383</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;MD Anderson Cancer Center Madrid&lt;/td&gt;</code></p><p><code>1384</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1385</code><code>                          &lt;/tr&gt;</code></p><p><code>1386</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Madrid, Spain  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1387</code><code>                                                          &lt;tr&gt;</code></p><p><code>1388</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Hospital Universitario Virgen del Rocio&lt;/td&gt;</code></p><p><code>1389</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1390</code><code>                          &lt;/tr&gt;</code></p><p><code>1391</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Sevilla, Spain  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1392</code><code>                                          &lt;/tbody&gt;</code></p><p><code>1393</code><code>      &lt;/table&gt;</code></p><p><code>1394</code><code>    &lt;/div&gt;</code></p><p><code>1395</code><code>  &lt;/div&gt;   </code></p><p><code>1396</code><code>  </code></p><p><code>1397</code><code>  &lt;!-- sponsors --&gt;</code></p><p><code>1398</code><code>      &lt;div class="ct-header3" style="margin-top:2ex"&gt;Sponsors and Collaborators&lt;/div&gt;</code></p><p><code>1399</code><code>              &lt;div class="tr-indent2" style="margin-top:1ex"&gt;Curis, Inc.&lt;/div&gt;</code></p><p><code>1400</code><code>        </code></p><p><code>1401</code><code>  &lt;!-- overall officials --&gt;</code></p><p><code>1402</code><code>  </code></p><p><code>1403</code><code>          </code></p><p><code>1404</code><code>&lt;/div&gt;</code></p><p><code>1405</code><code>&lt;/div&gt;</code></p><p><code>1406</code><code>						</code></p><p><code>1407</code><code>&lt;!-- more_info_section --&gt;</code></p><p><code>1408</code><code>          </code></p><p><code>1409</code><code>&lt;!-- Large docs section --&gt;</code></p><p><code>1410</code><code>          </code></p><p><code>1411</code><code>    </code></p><p><code>1412</code><code>          </code></p><p><code>1413</code><code>&lt;!-- More info section --&gt;</code></p><p><code>1414</code><code>  &lt;div class="tr-indent1" style="margin-top:3ex; border:1px solid white"&gt;</code></p><p><code>1415</code><code>  &lt;div class="tr-subsection"&gt;</code></p><p><code>1416</code><code>  	&lt;div class="ct-header2"&gt;&lt;a id="moreinfo"&gt;&lt;/a&gt;More Information&lt;/div&gt;</code></p><p><code>1417</code><code>  	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>1418</code><code>  	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>1419</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>1420</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>1421</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>1422</code><code>&lt;/button&gt;</code></p><p><code>1423</code><code>          </code></p><p><code>1424</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>1425</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>1426</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>1427</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>1428</code><code>          </code></p><p><code>1429</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>1430</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>1431</code><code>    </code></p><p><code>1432</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>1433</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>1434</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>1435</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>1436</code><code>  &lt;/div&gt;</code></p><p><code>1437</code><code>&lt;/div&gt;</code></p><p><code>1438</code><code>  &lt;/div&gt;</code></p><p><code>1439</code><code>  </code></p><p><code>1440</code><code>  &lt;div class="tr-indent2" style="margin-top:1em;"&gt;</code></p><p><code>1441</code><code>          </code></p><p><code>1442</code><code>          </code></p><p><code>1443</code><code>    &lt;!-- Additional Information --&gt;</code></p><p><code>1444</code><code>    </code></p><p><code>1445</code><code>          </code></p><p><code>1446</code><code>    &lt;!-- Available Study Data/Document --&gt;</code></p><p><code>1447</code><code>    </code></p><p><code>1448</code><code>          </code></p><p><code>1449</code><code>  &lt;!-- References --&gt;</code></p><p><code>1450</code><code>    </code></p><p><code>1451</code><code>    </code></p><p><code>1452</code><code>  &lt;!-- Derived References --&gt;</code></p><p><code>1453</code><code>    </code></p><p><code>1454</code><code>   </code></p><p><code>1455</code><code>  &lt;table class="ct-layout_table tr-tableStyle tr-moreInfo" style="margin-top:1ex;"&gt;</code></p><p><code>1456</code><code>    &lt;caption&gt;Layout table for additonal information&lt;/caption&gt;</code></p><p><code>1457</code><code>    &lt;thead&gt;</code></p><p><code>1458</code><code>    &lt;tr&gt;</code></p><p><code>1459</code><code>      &lt;th id="colTitle1"&gt;&lt;/th&gt;</code></p><p><code>1460</code><code>      &lt;th id="colData1"&gt;&lt;/th&gt;</code></p><p><code>1461</code><code>    &lt;/tr&gt;</code></p><p><code>1462</code><code>    &lt;/thead&gt;</code></p><p><code>1463</code><code>    &lt;tbody&gt;</code></p><p><code>1464</code><code>        &lt;tr&gt;</code></p><p><code>1465</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Responsible Party:&lt;/td&gt;</code></p><p><code>1466</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;Curis, Inc.&lt;/td&gt;</code></p><p><code>1467</code><code>    &lt;/tr&gt;</code></p><p><code>1468</code><code>        &lt;tr&gt;</code></p><p><code>1469</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;ClinicalTrials.gov Identifier:&lt;/td&gt;</code></p><p><code>1470</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;</code></p><p><code>1471</code><code>        &lt;a class="tr-study-link" title="Current version of study NCT04278768 on ClinicalTrials.gov" href="https://classic.clinicaltrials.gov/show/NCT04278768"&gt;NCT04278768&lt;/a&gt; &amp;nbsp; &amp;nbsp;</code></p><p><code>1472</code><code>        </code></p><p><code>1473</code><code>  &lt;script type="text/javascript"&gt;</code></p><p><code>1474</code><code>    &lt;!--</code></p><p><code>1475</code><code>    // Scramble access to archive site -</code></p><p><code>1476</code><code>    // don't want crawlers directing users to outdated versions of the study</code></p><p><code>1477</code><code>    // this should be opaque to crawlers that don't execute javascript</code></p><p><code>1478</code><code>    var yyy=new Array(</code></p><p><code>1479</code><code>      ['&lt;','a clas','s="tr-study','-link c', 't-now','rap" t','itle="Hist','orical vers','ions of '],</code></p><p><code>1480</code><code>      ['study ','NCT04278768',' on Clin','icalTrials.','go'],</code></p><p><code>1481</code><code>      ['v Ar','chive',' Sit','e" ','onc','lick="','openN','ewWin', 'dow(','\'/ct2/', 'history/'],</code></p><p><code>1482</code><code>      ['NCT04278768','\'); return', ' false;" '],</code></p><p><code>1483</code><code>      ['href','="/ct2/','history/','NCT04278768"','&gt;'],</code></p><p><code>1484</code><code>      ['Histo','ry of C','hange','s&lt;','/','a&gt;']);</code></p><p><code>1485</code><code>    var i=0;</code></p><p><code>1486</code><code>    var j=0;</code></p><p><code>1487</code><code>    var xxx='';</code></p><p><code>1488</code><code>    for (i=0; i&lt;yyy.length; i++)</code></p><p><code>1489</code><code>      for (j=0; j&lt;yyy[i].length; j++)</code></p><p><code>1490</code><code>        xxx+=yyy[i][j];</code></p><p><code>1491</code><code>    document.write(xxx)</code></p><p><code>1492</code><code>    --&gt;</code></p><p><code>1493</code><code>  &lt;/script&gt;</code></p><p><code>1494</code><code>          </code></p><p><code>1495</code><code>      &lt;/td&gt;</code></p><p><code>1496</code><code>    &lt;/tr&gt;</code></p><p><code>1497</code><code>            &lt;tr&gt;</code></p><p><code>1498</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Other Study ID Numbers:&lt;/td&gt;</code></p><p><code>1499</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;</code></p><p><code>1500</code><code>                                    CA-4948-102 &lt;br/&gt;</code></p><p><code>1501</code><code>                            &lt;/td&gt;</code></p><p><code>1502</code><code>    &lt;/tr&gt;</code></p><p><code>1503</code><code>            &lt;tr&gt;</code></p><p><code>1504</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;First Posted:&lt;/td&gt;</code></p><p><code>1505</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;February 20, 2020</code></p><p><code>1506</code><code>          &amp;nbsp;&amp;nbsp;</code></p><p><code>1507</code><code>          &lt;a class="tr-study-link ct-nowrap" href="/ct2/keydates/NCT04278768"</code></p><p><code>1508</code><code>                title="View key record dates for NCT04278768"</code></p><p><code>1509</code><code>                onclick="openNewWindow('/ct2/keydates/NCT04278768'); return false;"&gt;Key Record Dates&lt;/a&gt;</code></p><p><code>1510</code><code>      &lt;/td&gt;</code></p><p><code>1511</code><code>    &lt;/tr&gt;</code></p><p><code>1512</code><code>            &lt;tr&gt;</code></p><p><code>1513</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Last Update Posted:&lt;/td&gt;</code></p><p><code>1514</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;September 14, 2023</code></p><p><code>1515</code><code>      &lt;/td&gt;</code></p><p><code>1516</code><code>    &lt;/tr&gt;</code></p><p><code>1517</code><code>        &lt;tr&gt;</code></p><p><code>1518</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Last Verified:&lt;/td&gt;</code></p><p><code>1519</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;September 2023</code></p><p><code>1520</code><code>      &lt;/td&gt;</code></p><p><code>1521</code><code>    &lt;/tr&gt;</code></p><p><code>1522</code><code>           </code></p><p><code>1523</code><code>    &lt;!-- Plan to Share Data --&gt;</code></p><p><code>1524</code><code>          &lt;tr&gt;</code></p><p><code>1525</code><code>        &lt;td headers="colTitle1" class="ct-nowrap" colspan="2" style="padding-top:3ex;"&gt;Individual Participant Data (IPD) Sharing Statement:&lt;/td&gt;</code></p><p><code>1526</code><code>      &lt;/tr&gt;</code></p><p><code>1527</code><code>      &lt;tr&gt;</code></p><p><code>1528</code><code>        &lt;td headers="colTitle1" class="ct-nowrap" style="padding-left:1em;"&gt;Plan to Share IPD:&lt;/td&gt;</code></p><p><code>1529</code><code>        &lt;td headers="colData1" style="padding-left:1em"&gt;No&lt;/td&gt;</code></p><p><code>1530</code><code>      &lt;/tr&gt;</code></p><p><code>1531</code><code>                                      &lt;/tbody&gt;</code></p><p><code>1532</code><code>  &lt;/table&gt;</code></p><p><code>1533</code><code>          </code></p><p><code>1534</code><code>    &lt;br/&gt;</code></p><p><code>1535</code><code>  &lt;table class="ct-layout_table tr-tableStyle tr-moreInfo" style="margin-top:1ex"&gt;</code></p><p><code>1536</code><code>    &lt;caption&gt;Layout table for additional information&lt;/caption&gt;</code></p><p><code>1537</code><code>    &lt;thead&gt;</code></p><p><code>1538</code><code>    &lt;tr&gt;</code></p><p><code>1539</code><code>      &lt;th id="colTitle2"&gt;&lt;/th&gt;</code></p><p><code>1540</code><code>      &lt;th id="colData2"&gt;&lt;/th&gt;</code></p><p><code>1541</code><code>    &lt;/tr&gt;</code></p><p><code>1542</code><code>    &lt;/thead&gt;</code></p><p><code>1543</code><code>    &lt;tbody&gt;       </code></p><p><code>1544</code><code>        &lt;tr&gt;</code></p><p><code>1545</code><code>      &lt;td headers="colTitle2" class="ct-nowrap"&gt;Studies a U.S. FDA-regulated Drug Product:&lt;/td&gt;</code></p><p><code>1546</code><code>      &lt;td headers="colData2" style="padding-left:1em"&gt;Yes&lt;/td&gt;</code></p><p><code>1547</code><code>    &lt;/tr&gt;</code></p><p><code>1548</code><code>            &lt;tr&gt;</code></p><p><code>1549</code><code>      &lt;td headers="colTitle2" class="ct-nowrap"&gt;Studies a U.S. FDA-regulated Device Product:&lt;/td&gt;</code></p><p><code>1550</code><code>      &lt;td headers="colData2" style="padding-left:1em"&gt;No&lt;/td&gt;</code></p><p><code>1551</code><code>    &lt;/tr&gt;</code></p><p><code>1552</code><code>                    &lt;/tbody&gt;</code></p><p><code>1553</code><code>  &lt;/table&gt;</code></p><p><code>1554</code><code>  </code></p><p><code>1555</code><code>  </code></p><p><code>1556</code><code>    &lt;!-- keywords --&gt;</code></p><p><code>1557</code><code>        	</code></p><p><code>1558</code><code>    	    	  	&lt;div class="tr-tableLabel"&gt;Keywords provided by Curis, Inc.:&lt;/div&gt;</code></p><p><code>1559</code><code>    	    	&lt;div class="tr-indent3"&gt;</code></p><p><code>1560</code><code>          &lt;table class="ct-layout_table tr-moreInfo" style="width:100%;"&gt;</code></p><p><code>1561</code><code>    	      &lt;thead&gt;</code></p><p><code>1562</code><code>    	      &lt;tr&gt;</code></p><p><code>1563</code><code>    	        &lt;th id="keywordCol1" style="width:50%;"&gt;&lt;/th&gt;</code></p><p><code>1564</code><code>    	        &lt;th id="keywordCol2" style="width:50%;"&gt;&lt;/th&gt;</code></p><p><code>1565</code><code>    	      &lt;/tr&gt;</code></p><p><code>1566</code><code>    	      &lt;/thead&gt;</code></p><p><code>1567</code><code>    	      &lt;tr&gt;</code></p><p><code>1568</code><code>    	        &lt;td headers="keywordCol1" style="padding-left:1em;"&gt;</code></p><p><code>1569</code><code>    	              	          Acute Myelogenous Leukemia&lt;br/&gt;</code></p><p><code>1570</code><code>    	              	          Myelodysplastic Syndrome&lt;br/&gt;</code></p><p><code>1571</code><code>    	              	          AML&lt;br/&gt;</code></p><p><code>1572</code><code>    	              	          MDS&lt;br/&gt;</code></p><p><code>1573</code><code>    	              	          IRAK4&lt;br/&gt;</code></p><p><code>1574</code><code>    	              	          FLT3-ITD mutant&lt;br/&gt;</code></p><p><code>1575</code><code>    	              	          FLT3 Wild Type (WT)&lt;br/&gt;</code></p><p><code>1576</code><code>    	              	          resistant/refractory to HMA&lt;br/&gt;</code></p><p><code>1577</code><code>    	              	          spliceosome mutation&lt;br/&gt;</code></p><p><code>1578</code><code>    	              	        &lt;/td&gt;</code></p><p><code>1579</code><code>    	            	        &lt;td headers="keywordCol2" style="padding-left:1em;"&gt;</code></p><p><code>1580</code><code>    	              	          SF3B1&lt;br/&gt;</code></p><p><code>1581</code><code>    	              	          U2AF1&lt;br/&gt;</code></p><p><code>1582</code><code>    	              	          SRSF2&lt;br/&gt;</code></p><p><code>1583</code><code>    	              	          ZRSR2&lt;br/&gt;</code></p><p><code>1584</code><code>    	              	          high risk AML&lt;br/&gt;</code></p><p><code>1585</code><code>    	              	          high risk MDS&lt;br/&gt;</code></p><p><code>1586</code><code>    	              	          resistant/refractory to r/r to HMA&lt;br/&gt;</code></p><p><code>1587</code><code>    	              	          failing prior treatment&lt;br/&gt;</code></p><p><code>1588</code><code>    	              	        &lt;/td&gt;</code></p><p><code>1589</code><code>    	            	      &lt;/tr&gt;</code></p><p><code>1590</code><code>    	    &lt;/table&gt;</code></p><p><code>1591</code><code>    	&lt;/div&gt;</code></p><p><code>1592</code><code>    </code></p><p><code>1593</code><code>    &lt;!-- mesh terms --&gt;</code></p><p><code>1594</code><code>          &lt;div class="tr-tableLabel"&gt;Additional relevant MeSH terms:&lt;/div&gt;</code></p><p><code>1595</code><code>      &lt;div class="tr-indent3"&gt;</code></p><p><code>1596</code><code>        &lt;table class="ct-layout_table tr-meshTerms" style="width:100%;"&gt;</code></p><p><code>1597</code><code>          &lt;caption&gt;Layout table for MeSH terms&lt;/caption&gt;</code></p><p><code>1598</code><code>          &lt;thead&gt;</code></p><p><code>1599</code><code>          &lt;tr&gt;</code></p><p><code>1600</code><code>            &lt;th id="meshTermCol1" style="width:50%;"&gt;&lt;/th&gt;</code></p><p><code>1601</code><code>            &lt;th id="meshTermCol2"&gt;&lt;/th&gt;</code></p><p><code>1602</code><code>          &lt;/tr&gt;</code></p><p><code>1603</code><code>          &lt;/thead&gt;</code></p><p><code>1604</code><code>          &lt;tr&gt;</code></p><p><code>1605</code><code>            &lt;td headers="meshTermCol1" style="padding-left:1em;"&gt;</code></p><p><code>1606</code><code>                            Leukemia&lt;br/&gt;</code></p><p><code>1607</code><code>                            Preleukemia&lt;br/&gt;</code></p><p><code>1608</code><code>                            Leukemia, Myeloid&lt;br/&gt;</code></p><p><code>1609</code><code>                            Leukemia, Myeloid, Acute&lt;br/&gt;</code></p><p><code>1610</code><code>                            Myelodysplastic Syndromes&lt;br/&gt;</code></p><p><code>1611</code><code>                            Syndrome&lt;br/&gt;</code></p><p><code>1612</code><code>                            Disease&lt;br/&gt;</code></p><p><code>1613</code><code>                            Pathologic Processes&lt;br/&gt;</code></p><p><code>1614</code><code>                          &lt;/td&gt;</code></p><p><code>1615</code><code>                        &lt;td headers="meshTermCol1" style="padding-left:1em;"&gt;</code></p><p><code>1616</code><code>                            Neoplasms by Histologic Type&lt;br/&gt;</code></p><p><code>1617</code><code>                            Neoplasms&lt;br/&gt;</code></p><p><code>1618</code><code>                            Bone Marrow Diseases&lt;br/&gt;</code></p><p><code>1619</code><code>                            Hematologic Diseases&lt;br/&gt;</code></p><p><code>1620</code><code>                            Precancerous Conditions&lt;br/&gt;</code></p><p><code>1621</code><code>                            Venetoclax&lt;br/&gt;</code></p><p><code>1622</code><code>                            Antineoplastic Agents&lt;br/&gt;</code></p><p><code>1623</code><code>                          &lt;/td&gt;</code></p><p><code>1624</code><code>                      &lt;/tr&gt;</code></p><p><code>1625</code><code>        &lt;/table&gt;</code></p><p><code>1626</code><code>      &lt;/div&gt;</code></p><p><code>1627</code><code>    </code></p><p><code>1628</code><code>  &lt;br/&gt;</code></p><p><code>1629</code><code>          </code></p><p><code>1630</code><code>  &lt;!--</code></p><p><code>1631</code><code>        &lt;span class="ct-body3"&gt;ClinicalTrials.gov processed this record on September 26, 2023&lt;/span&gt;&lt;br/&gt;</code></p><p><code>1632</code><code>      --&gt;</code></p><p><code>1633</code><code>    &lt;br/&gt;  </code></p><p><code>1634</code><code>  &lt;/div&gt;</code></p><p><code>1635</code><code>   &lt;/div&gt;</code></p><p><code>1636</code><code>						</code></p><p><code>1637</code><code>			&lt;div id="to-top"&gt;&lt;a href="#wrapper"&gt;To Top&lt;/a&gt;&lt;/div&gt;</code></p><p><code>1638</code><code>			</code></p><p><code>1639</code><code>			&lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>1640</code><code>		&lt;/div&gt;</code></p><p><code>1641</code><code>	&lt;/div&gt;</code></p><p><code>1642</code><code>&lt;/div&gt;  </code></p><p><code>1643</code><code>&lt;div&gt;       &lt;div id="for-footer"&gt;</code></p><p><code>1644</code><code>        &lt;ul class="ct-horz-list"&gt;</code></p><p><code>1645</code><code>            &lt;li style="border-left:0;"&gt;&lt;a    href="/ct2/help/for-patient"&gt;For Patients and Families&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1646</code><code>            &lt;li&gt;&lt;a href="/ct2/help/for-researcher"&gt;For Researchers&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1647</code><code>            &lt;li&gt;&lt;a     href="/ct2/help/for-manager"&gt;For Study Record Managers&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1648</code><code>        &lt;/ul&gt;</code></p><p><code>1649</code><code>    &lt;/div&gt;</code></p><p><code>1650</code><code>	</code></p><p><code>1651</code><code>&lt;/div&gt;  </code></p><p><code>1652</code><code>&lt;div id="footer-menu" class="horz-line-above-menu"&gt;</code></p><p><code>1653</code><code>    &lt;ul class="ct-horz-list"&gt;</code></p><p><code>1654</code><code>		&lt;li&gt;&lt;a     href="/ct2/home"&gt;Home&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1655</code><code>		&lt;li&gt;&lt;a     href="/ct2/resources/rss"&gt;RSS Feeds&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1656</code><code>		&lt;li&gt;&lt;a     href="/ct2/sitemap"&gt;Site Map&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1657</code><code>		&lt;li&gt;&lt;a     href="/ct2/about-site/terms-conditions"&gt;Terms and Conditions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1658</code><code>		&lt;li&gt;&lt;a     href="/ct2/about-site/disclaimer"&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1659</code><code>		&lt;li&gt;&lt;a     href="https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;amp;category=clinicaltrials.gov&amp;amp;hd_url=http%3A%2F%2Fclassic.clinicaltrials.gov%2Fct2%2Fshow%2FNCT04278768%3Fterm%3DNCT04278768%26draw%3D2%26rank%3D1" onclick="openNewWindow('https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;amp;category=clinicaltrials.gov&amp;amp;hd_url=http%3A%2F%2Fclassic.clinicaltrials.gov%2Fct2%2Fshow%2FNCT04278768%3Fterm%3DNCT04278768%26draw%3D2%26rank%3D1'); return false"&gt;Customer Support&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1660</code><code>	&lt;/ul&gt;</code></p><p><code>1661</code><code>&lt;/div&gt;</code></p><p><code>1662</code><code>          </code></p><p><code>1663</code><code>&lt;/div&gt;  </code></p><p><code>1664</code><code>&lt;div id="fine-print"&gt;</code></p><p><code>1665</code><code>	&lt;ul class="ct-horz-list"&gt;</code></p><p><code>1666</code><code>		&lt;li &gt;&lt;a title="NLM copyright information - opens new window"  href="https://www.nlm.nih.gov/copyright.html" onclick="openNewWindow('https://www.nlm.nih.gov/copyright.html'); return false"</code></p><p><code>1667</code><code>&gt;Copyright&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1668</code><code>		&lt;li &gt;&lt;a title="NLM privacy policy - opens new window"  href="https://www.nlm.nih.gov/privacy.html" onclick="openNewWindow('https://www.nlm.nih.gov/privacy.html'); return false"</code></p><p><code>1669</code><code>&gt;Privacy&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1670</code><code>		&lt;li &gt;&lt;a href="/ct2/accessibility" title="NLM Accessibility"&gt;Accessibility&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1671</code><code>		&lt;li &gt;&lt;a title="NLM viewers and players - opens new window"  href="https://www.nlm.nih.gov/plugins.html" onclick="openNewWindow('https://www.nlm.nih.gov/plugins.html'); return false"</code></p><p><code>1672</code><code>&gt;Viewers and Players&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1673</code><code>		&lt;li &gt;&lt;a title="NIH Freedom of Information Act office - opens new window"  href="https://www.nih.gov/icd/od/foia/index.htm" onclick="openNewWindow('https://www.nih.gov/icd/od/foia/index.htm'); return false"</code></p><p><code>1674</code><code>&gt;Freedom of Information Act&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1675</code><code>		&lt;li &gt;&lt;a title="USA.gov - opens new window"  href="https://www.usa.gov/" onclick="openNewWindow('https://www.usa.gov/'); return false"</code></p><p><code>1676</code><code>&gt;USA.gov&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1677</code><code>		&lt;!--li &gt;&lt;a id="vdp" title="HHS Vulnerability Disclosure - opens new window"  href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" onclick="openNewWindow('https://www.hhs.gov/vulnerability-disclosure-policy/index.html'); return false"</code></p><p><code>1678</code><code>&gt;HHS Vulnerability Disclosure&lt;/a&gt;&lt;/li--&gt;</code></p><p><code>1679</code><code>		&lt;li&gt;</code></p><p><code>1680</code><code>			&lt;a id="vdp" </code></p><p><code>1681</code><code>				href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" </code></p><p><code>1682</code><code>				title="HHS Vulnerability Disclosure" </code></p><p><code>1683</code><code>				target="_blank"&gt;</code></p><p><code>1684</code><code>				HHS Vulnerability Disclosure</code></p><p><code>1685</code><code>			&lt;/a&gt;</code></p><p><code>1686</code><code>		&lt;/li&gt;</code></p><p><code>1687</code><code>	&lt;/ul&gt;</code></p><p><code>1688</code><code>    &lt;ul class="ct-horz-list"&gt;</code></p><p><code>1689</code><code>       &lt;li&gt;&lt;a title="U.S. National Library of Medicine - opens new window"  href="https://www.nlm.nih.gov/" onclick="openNewWindow('https://www.nlm.nih.gov/'); return false"</code></p><p><code>1690</code><code>&gt;U.S. National Library of Medicine&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1691</code><code>       &lt;li&gt;&lt;a title="U.S. National Institutes of Health - opens new window"  href="https://www.nih.gov/" onclick="openNewWindow('https://www.nih.gov/'); return false"</code></p><p><code>1692</code><code>&gt;U.S. National Institutes of Health&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1693</code><code>       &lt;li&gt;&lt;a title="U.S. Department of Health and Human Services - opens new window"  href="https://www.hhs.gov/" onclick="openNewWindow('https://www.hhs.gov/'); return false"</code></p><p><code>1694</code><code>&gt;</code></p><p><code>1695</code><code>            U.S. Department of Health and Human Services&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1696</code><code>    &lt;/ul&gt;</code></p><p><code>1697</code><code>&lt;/div&gt;</code></p><p><code>1698</code><code>          </code></p><p><code>1699</code><code>&lt;script type="text/javascript"&gt;__ncbi_sg_gaMode="clinicaltrials"&lt;/script&gt;</code></p><p><code>1700</code><code>&lt;script type="text/javascript" src="/ct2/html/js/pinger.js?v=2"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>1701</code><code>&lt;script type="text/javascript" src="/ct2/html/js/main-glossary.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>1702</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>1703</code><code>//OnSubmit routine - copy over some useful data and submit</code></p><p><code>1704</code><code>function sendSearchPing() {</code></p><p><code>1705</code><code>// Get pinger values</code></p><p><code>1706</code><code>var cVals = ncbi.sg.getInstance()._cachedVals;</code></p><p><code>1707</code><code>var app = cVals['ncbi_app'];</code></p><p><code>1708</code><code>var db = cVals['ncbi_db'];</code></p><p><code>1709</code><code>var pdid = cVals['ncbi_pdid'];</code></p><p><code>1710</code><code>var pcid = cVals['ncbi_pcid'];</code></p><p><code>1711</code><code>// Populate search details</code></p><p><code>1712</code><code>var searchDetails = {};</code></p><p><code>1713</code><code>searchDetails['jsevent'] = 'search';</code></p><p><code>1714</code><code>searchDetails['searchtext'] = jQuery('#header-search-query').val();</code></p><p><code>1715</code><code>if (app!=null) searchDetails['ncbi_app'] = app.value;</code></p><p><code>1716</code><code>if (db!=null) searchDetails['ncbi_db'] = db.value;</code></p><p><code>1717</code><code>if (pdid!=null) searchDetails['ncbi_pdid'] = pdid.value;</code></p><p><code>1718</code><code>if (pcid!=null) searchDetails['ncbi_pcid'] = pcid.value;</code></p><p><code>1719</code><code>// Send ping msg</code></p><p><code>1720</code><code>ncbi.sg.ping(searchDetails);</code></p><p><code>1721</code><code>};</code></p><p><code>1722</code><code>&lt;/script&gt;</code></p><p><code>1723</code><code>          </code></p><p><code>1724</code><code>          </code></p><p><code>1725</code><code>&lt;/body&gt;</code></p><p><code>1726</code><code>&lt;/html&gt;</code></p><div></div></main><iframe hidden="hidden" title="Hidden frame for spell checking" src="about:blank" id="iframeSpelling"></iframe></body></html>